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ABSTRACT 
Adiposity and cortisol regulation during daily living and exercise in adolescents  
with and without Down syndrome 
by 
E. Andrew Pitchford 
 
Chair: Dale A. Ulrich 
 
 Down syndrome is the most common genetic form of intellectual disability.  Overweight 
and obesity are highly prevalent among individuals with Down syndrome, representing a health 
disparity relative to the general population. Research on obesity in Down syndrome is limited by 
reliance on body mass index (BMI) to describe and classify this health condition.  Measuring 
adiposity with dual-energy x-ray absorptiometry (DXA) allows for three-compartment analysis 
including estimates of total and regional body composition and provides a better representation 
of adiposity in this unique population.  Factors that contribute to the higher prevalence of obesity 
in Down syndrome are not well understood, yet are critical for designing health promotion 
interventions to address this condition in Down syndrome.  The focus of this dissertation was to 
examine the associations between health behaviors (i.e. physical activity, dietary energy intake), 
cortisol, and adiposity in adolescents with and without Down syndrome. Three studies were 
conducted.  The first described adiposity using DXA and examined associations with physical 
activity and dietary energy intake.  The second and third studies examined cortisol, including 
 
ix 
diurnal patterns and responses to exercise, and associations with adiposity. The first study found 
significantly higher levels of body fat among adolescents with Down syndrome, particularly in 
the trunk region. However, the magnitude of difference compared to typically developing 
adolescents was considerably smaller than when examined with BMI, suggesting that BMI may 
be overestimating obesity in Down syndrome.  Physical activity showed a moderate association 
with adiposity.  The second study found that diurnal cortisol patterns were not significantly 
different between adolescents with and without Down syndrome. Differences in cortisol levels 
were observed between adolescents when stratified by the interaction of total body fatness and 
physical activity, indicating a joint effect on the association with adiposity. The third study 
attempted to compare the cortisol response to exercise between adolescents with and without 
Down syndrome, but neither group demonstrated a significant response.  When stratified by total 
body fatness, cortisol levels were moderately higher in adolescents with greater adiposity. These 
higher cortisol levels may help to partially explain levels of adiposity in adolescents with Down 
syndrome. Due to the high levels of obesity and low levels of physical activity, directed health 
promotion interventions are needed in this population.  
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CHAPTER 1 
DXA-derived body composition and health behaviors in adolescents with Down syndrome 
Introduction 
Childhood obesity in the general pediatric population poses a significant public health 
problem, with estimated rates continuing to track at epidemic levels (Karnik & Kanekar, 2012). 
Prevalence rates of overweight and obesity are currently estimated at 30.4% among adolescents 
in the United States (Ogden, Carroll, Kit & Flegal, 2014). This health condition is likely to 
continue into adulthood, increasing the risks of developing comorbidities and of early mortality 
(Reilly & Kelly, 2010). Youth with intellectual disabilities experience overweight and obesity 
with greater frequency than the general population (Rimmer, Yamaki, Davis, Wang & Vogel, 
2011; Rimmer, Yamaki, Lowry, Wang & Vogel, 2010; Segal et al., 2016), yet obesity and health 
behaviors (e.g. physical activity and dietary intake) remain understudied areas of research in  this 
‘at-risk’ population. 
 Down syndrome is the most common genetic form of intellectual disability (Sherman, 
Allen, Bean & Freeman, 2007). Recent prevalence rates range from 1/691 to 1/847 infants 
(Parker et al., 2010; Shin et al., 2009). Within this population, overweight and obesity are highly 
prevalent. Approximately 60% of youth with Down syndrome are estimated to be overweight 
(Bandini, Fleming, Scampini, Gleason & Must, 2012; Gonzalez-Aguero, Ara, Moreno, Vicente-
Rodriguez & Casajus, 2011; Grammatikopoulou et al., 2008; Harris, Rosenberg, Jangda, O'Brien 
& Gallagher, 2003; Myrelid, Gustafsson, Ollars & Anneren, 2002; Rimmer et al., 2010; Styles, 
Cole, Dennis & Preece, 2002; van Gameren-Oosterom et al., 2012); rates that far exceed the 
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general population (Ogden, Carroll, Kit & Flegal, 2012; Ogden et al., 2014). Multiple studies 
have demonstrated greater risk for obesity in youth with Down syndrome compared to typically 
developing peers (OR 3.00)(Rimmer et al., 2010) and youth with non-genetic intellectual 
disabilities (OR 1.97 to 3.21)(Bégarie, Maïano, Leconte & Ninot, 2013; Krause, Ware, 
McPherson, Lennox & O’Callaghan, 2015; Pan, Davis, Nichols, Hwang & Hsieh, 2016). Thus, 
obesity in youth with Down syndrome cannot be attributed to the effects of cognitive 
impairments alone. High rates of overweight and obesity persist and expand throughout 
adulthood (Bhaumik, Watson, Thorp, Tyrer & McGrother, 2008; Melville, Cooper, McGrother, 
Thorp & Collacott, 2005; Melville, Hamilton, Hankey, Miller & Boyle, 2008; Rubin, Rimmer, 
Chicoine, Braddock & McGuire, 1998; Stancliffe et al., 2011). In addition to the health risks 
associated with obesity, decreased community participation, challenges with independent living, 
and reductions in overall quality of life are also associated with obesity in persons with Down 
syndrome (Rimmer & Yamaki, 2006). 
However, the current evidence on obesity in Down syndrome is limited by over-reliance 
upon body mass index (BMI; kg/m2). The large range of prevalence estimates reported across 
youth with Down syndrome is likely due to unique study populations and the variety of obesity 
definitions and cut-offs employed (van Gameren-Oosterom et al., 2012). Due to short stature, a 
common characteristic of Down syndrome (Roizen & Patterson, 2003), BMI may overestimate 
excess fatness in this population. In particular, the 85th percentile on BMI-for-age growth charts 
appears to misclassify a large number of adolescents with Down syndrome as overweight when 
excess fatness is not present (Bandini et al., 2012). Overall efficiency (e.g. proportion correctly 
classified) was reported as only 69% (Bandini et al., 2012). Few studies have utilized dual 
energy x-ray absorptiometry (DXA), an advanced body composition measurement technique, in 
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persons with Down syndrome. DXA scans use low levels of radiation to measure fat mass, lean 
soft tissue, fat-free mass, and bone mineral content, allowing for estimates of total and regional 
body composition (Lohman & Chen, 2005). Limited evidence indicates adolescents and adults 
with Down syndrome have elevated body fat proportions, with greater fat mass and lower lean 
mass than typically developing controls (Bandini et al., 2012; Baptista, Varela & Sardinha, 2005; 
Esco, Nickerson, Bicard, Russell & Bishop, 2016; Gonzalez-Aguero et al., 2011; Guijarro, 
Valero, Paule, Gonzalez-Macias & Riancho, 2008; Loveday, Thompson & Mitchell, 2012; 
Nickerson et al., 2015; Wendel et al., 2016). Greater abdominal obesity (fat in the trunk region) 
has also been identified in adolescents with Down syndrome, particularly in females (Gonzalez-
Aguero et al., 2011). These findings suggest a unique body fat topology in Down syndrome, 
further violating the assumptions needed to apply BMI in this population and indicate that DXA-
derived fat mass can elucidate differences that are not available from standard anthropometry. 
Research utilizing DXA to study obesity in Down syndrome is critical to better understand and 
account for these systematic differences in body fat distribution. 
Despite the high prevalence of overweight and obesity among youth with Down 
syndrome, the factors that contribute to this health condition are not well understood. 
Researchers contend that low physical activity contributes to the obesity health disparity (Latash, 
Wood & Ulrich, 2008; Murray & Ryan-Krause, 2010; Rimmer & Rowland, 2008; van Gameren-
Oosterom et al., 2012); however, this relationship has not been empirically established in Down 
syndrome. Moderate-to-vigorous physical activity (MVPA) is a well-defined correlate of obesity 
in the general pediatric population (Jiménez-Pavón, Kelly & Reilly, 2010; Ness et al., 2007; 
Saelens, Seeley, van Schaick, Donnelly & O'Brien, 2007). Nutritional intake and dietary 
composition are also thought to contribute to obesity and secondary conditions. Multiple public 
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health organizations have stated a need to improve dietary quality in persons with intellectual 
disabilities (National Center for Health Statistics, 2012; Van Riper, 2010; World Health 
Organization, 2000). There remains a paucity of dietary intake data in this population, in 
particular for adolescents with Down syndrome.  
The objective data available on physical activity among individuals with Down syndrome 
is expanding, but currently inconclusive (Frey, Stanish & Temple, 2008; Pitetti, Baynard & 
Agiovlasitis, 2013). Reported estimates of youth that meet recommended physical activity 
guidelines (U.S. Department of Health and Human Services, 2008) range from 0% to 
approximately 40% (Esposito, MacDonald, Hornyak & Ulrich, 2012; Izquierdo-Gomez et al., 
2014; Matute-Llorente, González-Agüero, Gómez-Cabello, Vicente-Rodríguez & Casajús, 
2013a; Matute-Llorente, González-Agüero, Gómez-Cabello, Vicente-Rodríguez & Casajús, 
2013b; Phillips & Holland, 2011; Shields, Dodd & Abblitt, 2009), suggesting that youth with 
Down syndrome engage in insufficient levels of MVPA. However, Whitt–Glover et al. (2006) 
found children with Down syndrome (ages 3 to 10 years) to engage in very high levels of 
physical activity, with over 90% engaging in 60 minutes of moderate physical activity per day. 
Physical activity in this population appears to be a function of age, with all studies examining 
cross-sectional age trends showing significant declines through adolescence (Esposito et al., 
2012; Izquierdo-Gomez et al., 2014; Izquierdo-Gomez et al., 2015; Phillips & Holland, 2011; 
Shields et al., 2009; Shields, Hussey, Murphy, Gormley & Hoey, 2015). Additional studies have 
also statistically controlled for age in analyses to address this trend and had similar results 
(Matute-Llorente et al., 2013a; Matute-Llorente et al., 2013b; Whitt-Glover et al., 2006). Finally, 
it appears that youth with Down syndrome engage in less physical activity than typically 
developing controls (Matute-Llorente et al., 2013a; Matute-Llorente et al., 2013b; Phillips & 
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Holland, 2011; Whitt-Glover et al., 2006); however more studies are needed to confirm these 
differences.  
Total caloric intake and macronutrient distribution may also impact the development of 
obesity. Resting metabolic rate in youth with Down syndrome is significantly lower, thus many 
medical professionals recommend calorie restriction to prevent excess weight gain (Murray & 
Ryan-Krause, 2010; Roizen, 2002). However, youth and adults with Down syndrome have been 
shown to already consume less caloric energy compared to typical recommended dietary 
allowances (Fujiura, Fitzsimons, Marks & Chicoine, 1997; Hopman et al., 1998; Luke, Sutton, 
Schoeller & Roizen, 1996; Sharav & Bowman, 1992) and significantly fewer calories than 
typically developing controls or siblings (Hopman et al., 1998; Luke et al., 1996; Samarkandy, 
Mohamed & Al-Hamdan, 2012; Sharav & Bowman, 1992). It is unclear whether this caloric 
intake is sufficiently lower to account for differences in stature and metabolic rate among 
individuals with Down syndrome, or whether these values still contribute to the risk for obesity.  
While total energy intake is consistently lower in individuals with Down syndrome, the 
macronutrient profile of intake reported across studies is very consistent. Individuals with Down 
syndrome have been shown to consume macronutrients in typical proportions of daily calories 
from carbohydrate (53% to 60%), fat (28% to 30%) and protein (13% to 18%)(Braunschweig et 
al., 2004; Grammatikopoulou et al., 2008; Hopman et al., 1998; Luke et al., 1996; Samarkandy et 
al., 2012). This profile of macronutrient content does not appear to differ significantly between 
individuals with and without Down syndrome, nor does dietary energy intake differ greatly from 
recommended dietary allowance ranges (Grammatikopoulou et al., 2008; Luke et al., 1996; U.S. 
Department of Health and Human Services and U.S. Department of Agriculture, 2015).  
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However, there remain multiple gaps in the literature on diet in Down syndrome. Only 
one study has included a sample of adolescents (Grammatikopoulou et al., 2008) and few have 
examined daily caloric intake relative to weight (Braunschweig et al., 2004; Grammatikopoulou 
et al., 2008; Hopman et al., 1998). This methodology could be further improved by calculating 
energy intake relative to lean mass instead of total mass (Cameron et al., 2016). Lean body mass 
is strongly correlated with resting metabolic rate which represents the largest component of daily 
energy expenditure (Blundell, Gibbons, Caudwell, Finlayson & Hopkins, 2015). 
There is a need for more research describing physical activity and dietary energy intake 
in youth with Down syndrome, but also to understand how these health behaviors are associated 
with health outcomes such as obesity. A relationship between these health behaviors and body 
composition is the foundation for many health promotion practices intended to prevent excess 
weight gain. However, studies examining the association between MVPA and BMI have found 
surprisingly weak and non-statistically significant relationships (Esposito et al., 2012; Izquierdo-
Gomez et al., 2015; Nordstrom, Hansen, Paus & Kolset, 2013; Shields et al., 2009; Shields et al., 
2015). Very few studies have reported an association between dietary energy intake and BMI in 
Down syndrome, but findings are also weak, non-significant, and limited to adults with Down 
syndrome (Braunschweig et al., 2004; Fujiura et al., 1997). While it is possible that cross-
sectional relationships do not exist with these health behaviors, it is equally likely that BMI is an 
inappropriate index of body composition for use in the Down syndrome population. Precise 
measures of body composition that account for unique regional fat distributions are likely needed 
define such a relationship. The association between these health behaviors and adiposity in 
Down syndrome have not been examined using DXA.  
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The primary purpose of this study was to measure adiposity using an advanced 
measurement technique (DXA) capable of examining differences between adolescents with and 
without Down syndrome and associations with health behaviors. Three specific aims were 
addressed. First, the study compared group differences between adolescents with and without 
Down syndrome on body composition, physical activity, and dietary energy intake. Second, 
differences in the proportion of samples identified as overweight or obese were compared 
between BMI and DXA metrics. Third, the study examined the associations between physical 
activity, diet, and adiposity within each group. 
Methods 
Participants 
All methods and procedures for the study were approved by the Institutional Review 
Board of the University of Michigan Medical School. All parents signed written informed 
consent documents while participants completed written or verbal assessment prior to initiating 
the study. Adult participants (e.g. 18 years old) were allowed to independently provide written 
informed consent, however parents of adult participants with Down syndrome also provided 
written consent. Participants were recruited through Down syndrome parent support groups in 
Michigan and northern Ohio. Typically developing adolescents were recruited through family 
referrals, local school districts, and from previous study samples. All participants were between 
12 and 18 years old, Tanner stages III to V (Marshall & Tanner, 1969, 1970), and without dual 
disability diagnosis (e.g. autism), comorbid disease (e.g. diabetes), or contraindication limiting 
safe engagement in physical activity.  
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Procedures 
Phases. Each participant completed two phases of the study. First, participants completed 
a clinical visit with research staff at the Michigan Clinical Research Unit at the University of 
Michigan Hospital. The clinical visit included the informed consent process, measurement of 
body composition through standard anthropometry and a single DXA scan, and parental 
questionnaires for demographics and dietary assessment. Second, participants completed one 
week of accelerometry to measure habitual physical activity participation. Researchers trained 
both participants and parents in the accelerometer procedures during the clinical visit.  
Traditional Anthropometry. All anthropometric measurements were conducted 
according to guidelines from Lohman et al. (1988). Height and weight were measured in 
duplicate to the nearest 0.1 cm with a stadiometer (SECA S-214) and nearest 0.01 kg with a 
digital scale (Health O Meter H-349KL), respectively. If measures were more than 0.5 cm 
(height) or 0.5 kg (weight) apart, a third trial was conducted. The average across all trials was 
used to derive BMI (kg/m2). BMI percentile was also determined using sex-specific BMI-for-age 
growth references from the CDC (Kuczmarski et al., 2000). Overweight was defined as a BMI ≥ 
85th percentile and obesity was defined as ≥ 95th percentile. To determine how the current sample 
compared to other youth with Down syndrome, BMI percentile was also determined from sex- 
and age-specific growth curves for youth with Down syndrome ages 2 to 20 years (Zemel et al., 
2015). However, inferences regarding definitions for overweight or obesity in Down syndrome 
cannot be made from these charts.  
Dual-Energy X-Ray Absorptiometry. Each participant completed one whole-body 
DXA scan (GE Lunar Prodigy Advance [DPX-IQ 240] densitometer; Lunar Radiation Corp, 
Madison, WI) to measure body composition. Measurement through DXA provides a three-
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component analysis of body composition and is more cost-effective, time-efficient, and has 
minimal-risk, yet is correlated with more advanced imaging techniques (e.g. computed 
tomography and magnetic resonance imaging) making it a viable method for epidemiological 
research (Kendler et al., 2013). Reliability of the GE Lunar Prodigy has been established in 
pediatric populations for both total (ICC ≥ 0.98) and regional (ICC ≥ 0.97) estimates of body 
composition (Margulies et al., 2005). However, reliability evidence in populations with Down 
syndrome is not available. 
The scanner was calibrated daily according to the manufacturer’s instructions using a 
standardized block by the certified technician. Each DXA scan involves a low radiation dose 
(0.37 μSv); equivalent to the radiation absorbed during a typical day (Albanese, Diessel & 
Genant, 2003). This radiation dose is considered medically negligible. However, only one DXA 
scan was attempted per participant to minimize exposure as an additional safeguard.  
Participants wore wear light clothing, free of metallic objects, and were positioned in a 
supine position with hands by the sides in a neutral position. If needed, loose-fitting Velcro 
around the ankles or a warm blanket were used to assist the participant with maintaining position 
during the scan. While minimal movement did occur during some scans among participants with 
DS, all participants completed a DXA scan capable of analysis with the DXA software (EnCore 
v.14.10). The DXA scan provided measurements of fat mass, lean mass, fat-free mass, bone 
content, and percent body fat. Total-body and regional segments of arms, legs, and trunk were 
calculated using pediatric software. Ratios of fat mass distribution were then calculated including 
trunk-to-total, legs-to-total, arms-to-total, and arms and legs-to-trunk. The primary variables 
from the DXA scan used in analyses were the total and regional estimates of body fat percentage 
(%BF). Obesity was classified based on age- and sex-specific pediatric cut-points for elevated 
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body fat percentage (Freedman et al., 2009). Total-body lean mass from the DXA scan was also 
used to standardize dietary energy intake (kcal/lean kg). 
Questionnaires. All questionnaires were completed by the accompanying parent with the 
assistance of the participant to ensure consistency between participants with and without Down 
syndrome and minimize reporting bias due to intellectual disabilities (Emerson, Felce & 
Stancliffe, 2013).  
Sociodemographic survey. Parents completed a basic demographic survey including the 
participant’s age, sex, race and ethnicity, disability severity, current medication use and 
comorbidities, as well as parental age, education, and household income. 
Tanner Staging. To account for differences in pubertal development across adolescents, 
puberty stage was measured using Tanner stages (Marshall & Tanner, 1969, 1970). Parents 
completed a proxy-report questionnaire using schematic line drawings of pubertal development.  
Reports using line drawings have been shown to significantly correlate (boys: r = .59; girls: r = 
.81) with physician exam (Morris & Udry, 1980). Ratings on this scale range from I 
(prepubertal) to V (adult). Parental reports of pubertal stage have moderate agreement (r = 0.37 
to 0.71) with physician exams, but are prone to underestimate pubertal development in girls and 
overestimate in boys (Rasmussen et al., 2015). Due to the challenges with self-report in 
adolescents with Down syndrome and the invasiveness of a physical exam, the use of parental 
report is justified for the current study. Tanner stage was operationalized as the average of 
reported stages in pubic hair and genital development for males and breast and pubic hair 
development for females. Participants in the current study were limited to adolescents in Tanner 
stages III to V. 
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Dietary Intake. To estimate dietary energy intake and macronutrient distribution, a parent 
completed a proxy-report of the Harvard Youth/Adolescent Questionnaire (YAQ)(Rockett, Wolf 
& Colditz, 1995). This food frequency questionnaire (FFQ) assesses dietary behavior over the 
past year based on how often specific foods are consumed. The YAQ was selected for four 
reasons: a) it is a simple, self-administered assessment; b) there are no dietary assessments 
specifically validated for individuals with intellectual disabilities; c) the YAQ produces valid 
(r=0.45) and reliable (r=0.41) estimates of dietary energy intake (Rockett, Berkey & Colditz, 
2007; Rockett et al., 1997; Rockett et al., 1995); and d) FFQs have been used previously for 
persons with Down syndrome (Braunschweig et al., 2004). Parents completed the YAQ with the 
assistance of the participant with the researchers available to answer questions. Individual 
measures of total daily energy intake (kcals), macronutrient distributions from protein, available 
carbohydrate (total carbohydrate minus fiber), fiber, total fat, saturated fat, poly- and mono-
unsaturated fat, and cholesterol were calculated from estimates of the frequency of consumption 
of various foods. Daily energy intake per kilogram of lean mass (Cameron et al., 2016) was also 
calculated using data from the DXA scan and is the primary variable for dietary energy intake. 
The percentage of contribution to total calories for protein (4 kcals/g), carbohydrate (4 kcals/g), 
and fat (9 kcals/g) were also calculated.  
Physical Activity. Each participant wore an Actigraph GT3X+ (Pensacola, FL) triaxial 
accelerometer during waking hours for seven days at the waist to measure habitual physical 
activity. Waking hours were determined through a log completed by the parents and participants. 
All actigraphy data was collected at sampling frequency of 30 Hz with a 10-second epoch to 
capture intermittent movement. Criteria for minimum wear time included 10 hours per day for at 
least 4 days of the 7-day period, including at least one weekend day (Cain, Sallis, Conway, Van 
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Dyck & Calhoon, 2013). Each accelerometry file was manually cleaned to only include data 
collected between reported waking and bed times on each day and then assessed for non-wear 
time using validated algorithms (Choi, Liu, Matthews & Buchowski, 2011) with ActiLife 6 
software v6.9.5 (Actigraph, Pensecola, FL). Data were then reduced into physical activity 
intensity categories based on counts per minute (cpm): sedentary (<100 cpm), light physical 
activity (101-2295 cpm), moderate physical activity (2296-4011 cpm), and vigorous physical 
activity ( ≥ 4012 cpm), validated by Evenson et al. (2008). Cut-points were selected based on 
recommendations from a comparative study of cut-points in youth (Trost, Loprinzi, Moore & 
Pfeiffer, 2011) and evidence of moderate MVPA outcomes using this threshold (Loprinzi et al., 
2012). 
Data Analysis  
Data analyses were performed using SPSS 22.0 (IBM Corp., Armonk, NY) with an a 
priori α of 0.05. Demographics of the sample were described using independent t-tests and 
Pearson’s Chi-square (X 2) tests with effect sizes (i.e. Cohen’s d and Cramer’s V). Based on 
these statistics, groups exhibited equivalent distributions of demographic characteristics (e.g. 
age, sex, Tanner stage).  
First, multivariate analysis of covariance analyses (MANCOVA) were conducted to 
determine if groups with and without Down syndrome produced mean differences after adjusting 
for relevant covariates. Analyses were conducted in four sets: 1) body composition, 2) body fat 
distribution, 3) physical activity, and 4) dietary energy intake. The covariates included in all 
models were age, sex, and Tanner pubertal stage. Accelerometer wear-time was also a covariate 
for analyses on physical activity. Each analysis set was then repeated with separate analyses by 
sex groupings. Effect sizes including eta-squared (η2) from the adjusted MANCOVA analysis 
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and Cohen’s d from unadjusted group means were also calculated. Results were interpreted 
based on statistical significance of multivariate and univariate F tests and magnitude of effect 
sizes (Hopkins, Marshall, Batterham & Hanin, 2009; Sutlive & Ulrich, 1998). MANCOVA was 
used to reduce Type I error rate compared to a series of ANCOVA tests. 
  Second, differences in the proportion of samples identified as overweight or obese were 
compared between BMI and DXA metrics. Participants were coded as overweight if their BMI 
was greater or equal to the 85th percentile on the CDC growth reference (Kuczmarski et al., 
2000), obese if their BMI was greater or equal to 95th percentile (Kuczmarski et al., 2000), and as 
having elevated fat mass if total body fat percentage was greater or equal to age- and sex-specific 
cut-points from Freedman et al. (2009). Pearson’s Chi-square (X 2) tests with Cramer’s V effect 
sizes were used to examine differences in proportions across tests. Each analysis compared the 
proportion identified as overweight or obese with those identified as having an elevated fat mass. 
Chi-square analyses were conducted separately for adolescents with and without Down 
syndrome. 
Third, Pearson product-moment correlation coefficients and linear regression were used 
to examine the associations between physical activity, dietary intake, and adiposity. Pearson 
correlations were examined for all possible associations between body composition variables, 
physical activity variables, and total dietary energy intake normalized to lean body mass 
(kcal/lean kg). Analyses were conducted separately for males and females with Down syndrome. 
Correlations were interpreted based on statistical significance (p < .05) and the magnitude of the 
association (Hopkins et al., 2009; Sutlive & Ulrich, 1998). Linear regression analyses examined 
the association of total body fat percentage and Down syndrome diagnosis controlling for the 
effects of sex, age, Tanner pubertal stage, physical activity (MVPA minutes/day), and dietary 
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energy intake (kcal/lean kg). Results were interpreted based on the magnitude of standardized 
coefficients (β), statistical significance (p < .05), and effect size (η2). Semi-partial correlation (sr) 
and squared (sr2) coefficients were also calculated to examine the unique contributions of each 
factor to the total variance explained in the dependent variable. Subsequent analyses examined 
the same model, but separately for adolescents with and without Down syndrome to examine the 
differential effects of each factor within each group. 
Results 
 A total of 39 participants (22 with Down syndrome, 17 with typical development) 
participated in the study. Descriptive statistics and demographic information for the participants 
are presented in Table 1.1. All participants were between 12 and 18 years old and between 
Tanner stages III and V. Groups had equivalent distributions for age, sex, and Tanner pubertal 
stage (p > .10). Adolescents with Down syndrome were significantly shorter in stature than 
adolescents with typical development, t(37) = 5.82, p < .001; but were similar in weight, t(37) = 
0.51, p = .612. No statistical differences were observed between groups for any other 
demographic characteristics (p > .10).  
 Large differences were observed in body composition between groups (Table 1.2 and 
Figure 1.1). Adolescents with Down syndrome had significantly higher BMI (p = .001, d = 1.06) 
and BMI percentile based on CDC growth charts (p < .001, d = 1.31)(Kuczmarski et al., 2000). 
Down syndrome-specific growth charts characterized the sample at the 64th percentile (SE = 
4.08) on average (Zemel et al., 2015). Body fat percentages, measured via DXA, were also 
significantly higher among adolescents with Down syndrome (p < .05); however the magnitude 
of difference was considerably smaller than was observed for differences in BMI (d < .80). 
Significant differences were observed in body fat percentage for the total body as well as fat in 
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regional segments at the arms, legs, and trunk. Sex was a significant covariate for multiple 
indices of body composition. When separated by sex (Table 1.3 and Figure 1.2), significant 
differences in BMI and BMI percentile persisted for both males (p < .05, d > .80) and females (p 
< .05, d > 1.00). Body fat percentages were significantly greater among males with Down 
syndrome for the total body, trunk, and arms (p < .05, d >.80), and trended toward statistical 
significance for the legs region (p = .052, d =.862). Statistically significant differences were not 
observed among females (p > .10), but females with Down syndrome averaged higher body fat 
percentages of a moderate magnitude (d > .60). Compared to other youth with Down syndrome, 
males with Down syndrome were considerably more overweight (74th percentile, SE = 4.99) 
than females (45th percentile, SE = 8.08). 
 To further examine body composition, ratios between regional segments of body fat were 
calculated. Table 1.4 and Figure 1.3 present the group differences in these body fat ratios. Large 
and statistically significant differences were observed between group for ratios of trunk-to-total 
(p < .001, d =1.19), legs-to-total (p < .001, d =1.32), and arms and legs-to-trunk (p < .001, d 
=1.23). No differences were observed in the ratio of arms-to-total body fat (p = .600, d =.264). 
Each of these ratios indicated greater fat mass in the trunk (e.g. abdomen) among adolescents 
with Down syndrome. Table 1.5 and Figure 1.4 show similar group differences when stratified 
by sex. 
 The differences observed in BMI and percent body fat indices affected the prevalence of 
adolescents categorized as being overweight and obese, depending on whether classifications 
were based on BMI or body fatness. Table 1.6 presents a series of 2x2 tests comparing the 
proportions of the sample categorized as obese or overweight based on the CDC growth curve 
(Kuczmarski et al., 2000) versus proportions of the sample with normal or elevated body fat 
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percentage (Freedman et al., 2009) as measured by DXA. Adolescents with Down syndrome 
exhibited high levels of obesity and were categorized as 70.2% overweight, 41.0% obese, and 
38.6% with elevated body fatness. Adolescents with typical development had lower levels of 
obesity and were categorized as 20.9% overweight, 17.5% obese, and 20.6% with elevated body 
fatness. 31.8% of adolescents with Down syndrome who were categorized as overweight based 
on the CDC growth charts (Kuczmarski et al., 2000) did not exhibit elevated body fatness 
(Freedman et al., 2009). Furthermore, 18.2% of adolescents with Down syndrome categorized as 
obese did not have elevated body fatness. An additional 13.6% had elevated body fatness, but 
were not categorized as obese. In total, only 68.2% of adolescents with Down syndrome were 
properly categorized. No substantial discrepancies in classification (< 6%) were observed in 
typically developing adolescents. Figure 1.5 shows the significant differences in adolescents 
with and without Down syndrome categorized as overweight, F(1,34) = 12.67, p = .001, partial 
η2 = .272, d = 1.30; and differences in overweight and elevated body fat classification within 
adolescents with Down syndrome (t(21) = 3.13, p = .005, d = .664). 
 Physical activity levels were very low among most participants. Fewer than 5% of 
adolescents with Down syndrome and fewer than 20% of adolescents with typical development 
met physical activity guidelines of 60 minutes of MVPA per day (U.S. Department of Health and 
Human Services, 2008). Table 1.7 and Figure 1.6 present the group differences for each 
physical activity intensity category. Adolescents with Down syndrome averaged 27.83 (SE = 
5.43) minutes of MVPA per day compared to 45.76 (SE = 6.21) minutes per day among 
adolescents with typical development, while controlling for age, sex, pubertal stage, and wear 
time (60 minutes per day). Significant differences between groups were observed for MVPA (p = 
.041, d = .421), vigorous physical activity (p = .011, d = .617), and light physical activity (p < 
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.001, d = .110). No differences were observed in sedentary time (p = .104, d = .146) or moderate 
physical activity (p = .264, d = .098). When stratified by sex (Table 1.8 and Figure 1.7) only 
light physical activity was significantly different among both males (p = .013, d = 1.15) and 
females (p = .009, d = .957), while vigorous physical activity was significantly different among 
males only (p = .037, d = .867). 
 Dietary energy intake was also different between groups (Table 1.9 and Figure 1.8). 
Estimates of raw energy intake were significantly lower among adolescents with Down 
syndrome including total energy (kcals/day; p = .023, d = .761), carbohydrates (g/day; p = .035, 
d = .688), and fat (g/day; p = .015, d = .794). However, when energy intake as normalized to lean 
body mass (kg), significant differences were no longer observed (kcal/kg/day; p = .369, d = 
.382). Macronutrient distributions were also not significantly different when normalized to total 
energy intake (p > .10, d < .350). On average, adolescents in the sample consumed most calories 
from carbohydrates (53.58%), fat (30.00%), and protein (17.40%). Table 1.10 and Figure 1.9 
show how differences in dietary energy intake were moderated by sex. Among females, 
significant differences were observed in raw energy and macronutrient intake (p < .05, d > .900). 
Macronutrient content normalized to total energy intake were not significantly different between 
groups (p > .30, d < .700). Total energy intake normalized to lean body mass was not statistically 
different between groups (p = 0.70), but exhibited a large effect size (d = .997). Among males, 
there were neither significant group differences (p > .05) nor large effect sizes (d < .800). 
 Table 1.11 shows the correlations between measurements of body composition and 
physical activity for adolescents with Down syndrome and typical development. The primary 
purpose was to examine the association between MVPA and each index of obesity. In 
adolescents with Down syndrome, the associations between MVPA and BMI (r = -.015), and 
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BMI percentile (r = .021) were very low. The associations between MVPA and body fat 
percentages including total body (r = -.233), trunk (r = -.217), legs (r = -.237), and arms (r = -
.230), were stronger, but these associations did not reach statistical significance (p > .05). A 
similar pattern was observed for these associations among typically developing adolescents with 
larger magnitudes of association between MVPA and body fat percentages compared to 
associations with BMI, but these were also not statistically significant (p > .05). Statistically 
significant correlations among adolescents with Down syndrome were observed between light 
physical activity and all measures of body composition (r > .500, p < .05). Among typically 
developing adolescents, statistically significant correlations were observed between vigorous 
physical activity and total body, trunk, and leg region body fat percentage (r > .400, p < .05).  
 Finally, Table 1.12 presents linear regression analyses examining the associations of sex, 
age, Tanner stage, MVPA, dietary energy intake, and presence of Down syndrome on total body 
fat percentage. The first analysis examined this relationship for all participants in the sample and 
explained a large portion of variance in total body fat percentage, F(6,32) = 3.55, p = .008, R2 = 
.400. Significant factors affecting total body fat percentage included age (β = 0.52, p = .031), 
Tanner stage (β = -0.58, p = .005), and presence of Down syndrome (β = 0.34, p = .027). Semi-
partial correlation coefficients (sr2) suggested that the independent contribution to total variance 
explained was largest for Tanner stage (17.30%), Down syndrome (10.0%), and age (9.50%). 
The analysis was repeated separately for adolescents with and without Down syndrome. The 
linear model explained 60% of the variance in total body fat percentage among adolescents with 
Down syndrome, F(5,21) = 4.88, p = .007, R2 = .604, but only Tanner stage remained as a 
statistically significant predictor (β = -0.79, p = .001), accounting for 44.5% of total variance. 
The same model explained 31% of the variance in total body fat percentage among adolescents 
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with typical development, F(5,16) = 1.01, p = .457, R2 = .315, with no statistically significant 
predictors (p > .05).  
Discussion 
The primary purpose of this study was to examine the associations between body 
composition and the health behaviors of physical activity and dietary energy intake in 
adolescents with Down syndrome. The main findings showed that: (i) physical activity is not 
significantly associated with body composition; however, the magnitude of association is 
considerably stronger when using body fat percentage from DXA; (ii) estimates of obesity 
proportions are different between metrics of BMI compared to body fat from DXA; and (iii) 
there are significant differences in adiposity, physical activity, and dietary intake between 
adolescents with Down syndrome and typical development that may be clinically relevant.  
Overweight and obesity are clearly an issue of health disparity in Down syndrome. 
Previous studies in adolescents with Down syndrome have estimated the prevalence of 
overweight between 32% and 60% (Bandini et al., 2012; Gonzalez-Aguero et al., 2011; 
Grammatikopoulou et al., 2008; Harris et al., 2003; Myrelid et al., 2002; Rimmer et al., 2010; 
Styles et al., 2002; van Gameren-Oosterom et al., 2012) while the current sample categorized 
approximately 70% of adolescents with Down syndrome as overweight based on BMI percentile. 
Given the high rates of overweight and obesity among adolescents with Down syndrome, 
targeted health promotion is of particular need for this at-risk population. 
The associations presented in this study add to a small but growing body of literature 
examining health behaviors and obesity in youth with Down syndrome. In the general 
population, higher levels of physical activity have been associated with lower levels of body 
fatness (Katzmarzyk et al., 2015; Mitchell et al., 2013; Ortega, Ruiz & Castillo, 2013). A limited 
20 
number of studies have examined such an association in persons with Down syndrome and have 
largely found weak and non-statistically significant relationships (Esposito et al., 2012; 
Izquierdo-Gomez et al., 2015; Nordstrom et al., 2013; Shields et al., 2009; Shields et al., 2015). 
In the current study, the associations between MVPA and BMI for males and females with Down 
syndrome (r = -.17 and -.34, respectively) were similar to other reported associations ranging 
from r = -.05 to -.30 (Esposito et al., 2012; Shields et al., 2009; Shields et al., 2015). However, 
when using body fat percentage from DXA, the associations with MVPA were much stronger. 
Correlation coefficients (r) exceeded -.40 for males and -.50 for females, indicating a larger 
magnitude of association of MVPA with body fat compared to BMI. Similarly large associations 
were observed between MVPA and regional body fat in the trunk, legs, and arms. While 
correlations did not reach statistical significance, the large magnitude suggests that with greater 
sample size, statistical significance could be observed.  
Given the improved magnitude of association between body fat and MVPA, it was 
important to examine the relationship of physical activity on body fat while controlling for other 
relevant covariates. A significant association was observed between the presence of Down 
syndrome and total body fat percentage, as was expected. However, other relevant factors also 
exhibited significant associations with total body fat percentage including Tanner pubertal stage, 
but not sex or age. The association of MVPA, controlling for other factors, with total body fat 
percentage trended toward statistical significance (p = .076), but still accounted for a large 
portion of the variance explained. Average caloric intake did not present significant associations 
with percent body fat in any model. When broken down into separate analyses for disability 
groups, the significant association of Tanner stage and trending association of MVPA persisted 
for adolescents with Down syndrome. The lack of association between body composition and sex 
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or age is consistent with previous findings (Krause et al., 2015), but the strong association with 
Tanner stage is novel and has not been previously addressed in this population. Interestingly, 
Tanner stage and body fat in adolescents with Down syndrome were negatively associated, 
suggesting lower body fatness at higher Tanner stages. Adiposity has been shown to decrease in 
typically developing adolescents from mid- to post-puberty, particularly among boys (Crocker et 
al., 2014). 
To my knowledge, the only other study to examine associations between physical activity 
and body composition in adolescents with Down syndrome using similar methodology found no 
associations (Izquierdo-Gomez et al., 2015). Demographics, including age, weight, height, BMI, 
and body fat, were similar between studies; however, participants in the Izquierdo-Gomez et al. 
(2015) sample engaged in approximately 56 minutes of MVPA per day. It is possible that the 
high rates of adiposity and very low rates of physical activity in the current study are inflating 
these associations. Izquierdo-Gomez et al. (2015) suggest that physical activity levels may not 
contribute to fatness in this population, but longitudinal studies of this relationship are needed to 
make such inferences. However, given that my analysis controlled for multiple relevant factors 
including sex, age, and Tanner stage, the resulting association and variance explained suggest 
there is at least a moderate relationship to consider. 
The second purpose of the study was to compare differences in body composition using 
traditional anthropometry with BMI and estimates of body fat percentage from DXA. The 
literature on youth with Down syndrome consistently shows greater BMI and higher proportions 
of overweight and obesity compared to typically developing youth (Bandini et al., 2012; 
Grammatikopoulou et al., 2008; Harris et al., 2003; Izquierdo-Gomez et al., 2015; Myrelid et al., 
2002; Rimmer et al., 2010; Styles et al., 2002; van Gameren-Oosterom et al., 2012). The results 
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from DXA measurements tell a similar, but different story. When controlling for sex, age, and 
Tanner pubertal stage there were statistically significant differences in BMI and BMI percentile 
between groups with very large effect sizes. Differences in total body fat percentage from DXA 
were also statistically significant between groups, but the effect size was only moderate (Hopkins 
et al., 2009). The decrease in magnitude suggests that differences in adiposity between 
adolescents with and without Down syndrome based on the CDC growth charts may be inflated.  
  I examined a similar issue comparing BMI categories with DXA adiposity in 
adolescents and young adults with Down syndrome. Substantial discrepancies were reported, in 
particular a low efficiency of the 85th percentile compared to elevated fat mass. While I did not 
address all aspects of classification function (i.e. specificity, sensitivity, etc.), the present analysis 
also showed substantial misidentification of overweight at the 85th percentile compared to 
elevated fat mass. Nearly 32% of adolescents with Down syndrome categorized as overweight 
based on the CDC growth chart 85th percentile did not present with elevated fat mass. These 
results are consistent with findings of low overall efficiency in overweight and obese 
classification among adolescents with Down syndrome (Bandini et al., 2012). A control group 
was not included in the Bandini et al. (2012) analysis on elevated body fat and BMI 
classifications, but the classification of typically developing adolescents in the present study 
appears to be appropriate.  
The high body fat percentage observed in this sample of adolescents with Down 
syndrome (33.20%) is consistent with previous studies that have measured adiposity with DXA 
in persons with Down syndrome (26.99% - 39.94%)(Bandini et al., 2012; Baptista et al., 2005; 
Esco et al., 2016; Guijarro et al., 2008; Loveday et al., 2012; Nickerson et al., 2015; Wendel et 
al., 2016). However, Gonzalez-Aguero et al. (2011) reported a lower body fat percentage 
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(24.7%) compared to other DXA studies in Down syndrome. This was among a sample of youth 
with Down syndrome ages 10 to 19 years matched on BMI. Despite the lack of group matching 
in the present study, similar differences in regional body fat distribution were observed. 
Adolescents with Down syndrome had significantly higher body fat percentages in the trunk 
region and both body fat distribution ratios suggest a greater proportion of total body fat is stored 
in the abdomen. Gonzalez-Aguero et al. (2011) found a similar trend toward abdominal obesity 
with greater fat mass among adolescents with Down syndrome, particularly among girls. These 
findings reflect a unique body fat topology in Down syndrome that BMI is not capable of 
describing. While significant differences are evident using both traditional anthropometry and 
the advanced DXA measurement, the differences seen across regional segments and distribution 
ratios confirm that more detailed measurements are highly useful in this population. When 
feasible and cost-effective (Kendler et al., 2013), the use of DXA to measure body composition 
in adolescents with Down syndrome is suggested. 
The third purpose of the study was to examine differences in physical activity and dietary 
behaviors between adolescents with and without Down syndrome. These findings continue the 
description of physical activity in adolescents with Down syndrome. While more research efforts 
need to be funneled toward understanding correlates of physical activity and designing 
interventions to increase physical activity behavior in adolescents with Down syndrome, there is 
still insufficient literature to thoroughly describe the physical activity patterns of this population 
(Frey et al., 2008; Pitetti et al., 2013). In the current sample, only four of the 39 participants 
(10%) including one adolescent with Down syndrome (4.5%) and three adolescents with typical 
development (17.65%) met the guidelines of 60 minutes of MVPA per day (U.S. Department of 
Health and Human Services, 2008). Previous studies have also shown a very low proportion of 
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adolescents with Down syndrome engaging in adequate physical activity (Esposito et al., 2012; 
Izquierdo-Gomez et al., 2014; Matute-Llorente et al., 2013a; Matute-Llorente et al., 2013b; 
Phillips & Holland, 2011; Shields et al., 2009), including three studies that found 0% of the 
sample with Down syndrome met guidelines (Matute-Llorente et al., 2013a; Matute-Llorente et 
al., 2013b; Phillips & Holland, 2011). The average MVPA among the adolescents with Down 
syndrome was approximately 27 minutes per day after controlling for sex, age, Tanner stage, and 
wear time. The typically developing adolescents also engaged in largely insufficient levels of 
MVPA as well, averaging only 44 minutes of MVPA per day. Measured MVPA in this sample 
was consistent with previous reports among adults with Down syndrome (25 to 30 minutes per 
day)(Nordstrom et al., 2013; Phillips & Holland, 2011), but below previously reported levels for 
adolescents with Down syndrome (56 to 85 minutes per day)(Izquierdo-Gomez et al., 2014; 
Izquierdo-Gomez et al., 2015; Shields et al., 2009). Age may be relevant in this relationship, as 
MVPA has been shown to decrease with increasing age both within youth (Esposito et al., 2012; 
Izquierdo-Gomez et al., 2014; Shields et al., 2009) and into adulthood (Phillips & Holland, 2011) 
in individuals with Down syndrome. Interpreting differences in physical activity across studies is 
challenging due to the variety of accelerometers used to measure physical activity and cut-points 
employed to categorize time spent in different intensities. Furthermore, all physical activity data 
from accelerometers should be interpreted cautiously due to the lack of validated cut-points for 
this population. While cut-points from the general population may be useful when applied to 
other populations, the known differences in heart rate response, energy expenditure, and gait in 
individuals with Down syndrome (Pitetti et al., 2013) may limit the usefulness of general 
population cut-points in this population. This issue has been demonstrated in adults (Agiovlasitis 
et al., 2011; Agiovlasitis, Motl, Foley & Fernhall, 2012), but is likely also relevant in youth with 
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Down syndrome. Despite these methodological issues, increasing levels of phyical activity 
among adolescents with Down syndrome continues to be an area of great need.  
The low levels of physical activity in adolescents with Down syndrome may also have 
implications for physical fitness. In the general population, obesity is strongly associated with 
lower levels of physical fitness (Rauner, Mess & Woll, 2013). Cardiovascular and muscular 
fitness are both significantly lower in Down syndrome (Gonzalez-Aguero et al., 2010; Izquierdo-
Gomez, Martinez-Gomez, Fernhall, Sanz & Veiga, 2016; Izquierdo-Gomez et al., 2013; 
Izquierdo-Gomez et al., 2015). Recent studies have found that physical activity levels are 
positively associated with cardiovascular and muscular fitness in adolescents with Down 
syndrome (Izquierdo-Gomez et al., 2015; Matute-Llorente et al., 2013a). Significant negative 
associations between BMI, waist circumference, and cardiovascular fitness have also been 
shown (Shields et al., 2015), while other studies have not found significant relationships within 
samples of youth with Down syndrome (Izquierdo-Gomez et al., 2016; Izquierdo-Gomez et al., 
2015). While these relationships have not been examined through longitudinal studies, there is at 
least cross-sectional evidence that a healthy profile characterized by low body fat, greater levels 
of physical activity, and higher physical fitness is possible in youth with Down syndrome. 
Finally, the present study adds to a very small body of literature on dietary energy intake 
patterns of people with Down syndrome. Raw values of daily caloric and macronutrient intake 
were significantly lower among adolescents with Down syndrome compared to typical 
development. This is consistent with nearly all research on diet in youth and adults with Down 
syndrome (Fujiura et al., 1997; Hopman et al., 1998; Luke et al., 1996; Samarkandy et al., 2012; 
Sharav & Bowman, 1992). The novel approach of this study was to also examine caloric intake 
normalized to lean body mass. Once caloric intake was normalized, differences between Down 
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syndrome and typical development were no longer present. Although there were no differences 
in weight between groups, lean mass was significantly lower in adolescents with Down 
syndrome. This difference was sufficient to account for the gap in energy intake. Previous 
studies in Down syndrome have also normalized calorie intake to total body mass (Braunschweig 
et al., 2004; Grammatikopoulou et al., 2008; Hopman et al., 1998). However, the only other 
study to both normalize energy intake to body weight and compare kcals/kg between youth with 
and without Down syndrome (Hopman et al., 1998) also found significantly lower kcal but 
similar kcal/kg intake in children with Down syndrome. However, this study was conducted in 
children between the ages of 1 and 4 years, so additional comparisons have limited meaning to 
the current sample of adolescents. Even after controlling for lean mass, adolescents with Down 
syndrome had lower average kcal/kg intake than typically developing peers. This suggests that 
dietary practices alone are unlikely to be a primary contributor to excess fatness.  
Macronutrient consumption levels were also lower among adolescents with Down 
syndrome, but when normalized to total energy there were no longer significant differences. 
Estimated macronutrient intake levels (53% from carbohydrates, 30% from fat, and 18% from 
protein) were also within the recommended daily allowances (U.S. Department of Health and 
Human Services and U.S. Department of Agriculture, 2015). This macronutrient profile was not 
significantly different from adolescents with typical development and was consistent with 
previous literature in person with Down syndrome (Braunschweig et al., 2004; 
Grammatikopoulou et al., 2008; Hopman et al., 1998; Luke et al., 1996; Samarkandy et al., 2012; 
Soler Marin & Xandri Graupera, 2011). However, the current analysis does not account for the 
quality of dietary intake. Previous studies have shown that individuals with Down syndrome do 
not consume appropriate portions of healthy foods such as fruits and vegetables (Braunschweig 
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et al., 2004). It also remains unclear if the lower caloric intake observed is sufficient to account 
for the lower resting metabolic rate observed in persons with Down syndrome (Murray & Ryan-
Krause, 2010; Roizen, 2002). Given the paucity of studies in this area, additional research on diet 
and obesity in this population are needed. 
The current study is limited by a number of important factors that should be considered 
when interpreting the findings presented. First, the study includes a relatively small convenience 
sample, which limited statistical power. While groups were statistically similar for age, sex, and 
Tanner pubertal stage, there was a considerable difference in the distribution of sex between 
groups. This discrepancy could have influenced the effect of sex observed in multiple analyses. 
Furthermore, while statistically significant results were observed in many analyses using the full 
sample, many of the follow-up analyses stratified by sex did not present significant differences. 
Dividing a limited sample size into separate groups further reduced statistical power. The data is 
also cross-sectional in nature, so casual inferences cannot be made. Given the small sample, 
differences observed across subgroupings may also be skewed. There were multiple issues with 
recruiting participants for this study due to the time and effort needed to complete the DXA scan 
at the MCRU. Therefore, the sample may not be representative and the findings generalizable to 
the broader population of adolescents with Down syndrome. 
Second, physical activity was measured using accelerometers with psychometric 
properties and cut-point procedures for the general population. The current physical activity 
literature in Down syndrome should be viewed cautiously, as psychometric evidence for 
accelerometer use in this population is limited. Due to differences in energy expenditure 
(Agiovlasitis et al., 2011; Agiovlasitis et al., 2012), the validity of accelerometer cut-points 
derived from the general population for individuals with Down syndrome is highly questionable. 
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Alternative cut-points have been proposed for adults with Down syndrome (Agiovlasitis et al., 
2011; Agiovlasitis et al., 2012), but still require external validation. Examinations of cut-points 
in youth with Down syndrome have not been published to date. Additionally, the selection of the 
Evenson et al. (2008) cut-points may also influence the interpretation of findings, as the time 
classified in MVPA may have been very different using an alternative set of cut-points (e.g. 
Freedson, Pober & Janz, 2005). Loprinzi et al. (2012) found that, based on accelerometer data 
from NHANES 2003-2006, youth participated in 44.5 minutes of MVPA per day using the 
Evenson cut-points, but 59.4 minutes of MVPA using the Freedson cut-points. This translates to 
interpreting the same data as 45.7% or 59.3% of youth meeting physical activity guidelines. 
Differences between cut-points and the wide range of cut-points used in the literature hinder the 
ability to compare findings across studies. 
Third, both diet and Tanner stage were measured through questionnaires and with 
parental proxy reporting. These procedures were selected to address issues with self-report 
(Emerson et al., 2013). Dietary assessments such as the YAQ and other FFQs have not been 
validated in youth with disabilities, so it is not possible to determine how accurately the dietary 
information reflects actual behavior (Braunschweig et al., 2004). However, all participants in the 
study lived with the parent completing the questionnaire and assisted with the process. Similar 
issues limit the potential accuracy of the Tanner stage assessment. While parents have been 
shown to provide acceptable estimates of Tanner stage using this methodology (Rasmussen et 
al., 2015), these validity studies did not include adolescents with disabilities. Given that Tanner 
stage was an important covariate in the linear regression analysis, a future study with a direct 
physician exam of Tanner stage is recommended to confirm the current findings. 
29 
 Despite these limitations, this study demonstrated significantly higher levels of 
overweight, obesity, and excess fatness among adolescents with Down syndrome, provided 
additional evidence for unique body fat distribution in this population, highlighted the pervasive 
low levels of physical activity, added another example of consistent dietary profile, and 
demonstrate that a moderate associative relationship can be observed between adiposity and 
physical activity levels if adiposity is properly measured. Future research should continue to 
examine the causes and consequences of greater obesity in Down syndrome and develop novel 
interventions to address health disparities.  
In conclusion, it is clear that overweight and obesity are pervasive among adolescents 
with Down syndrome, representing a source of health disparity. Due to unique body fat topology, 
BMI is an inadequate metric of adiposity. Future studies should utilize DXA or other 
methodologies capable of capturing abdominal obesity. The results also show a moderate 
association between physical activity and adiposity. Though causal nature cannot be inferred, 
this is the first study to show even a mild association between these variables in persons with 
Down syndrome, suggesting a potential relationship between this health behavior and health 
condition. Future studies should continue to create innovative interventions and health promotion 
programming to increase physical activity levels in adolescents with Down syndrome. The 
information presented here may also be relevant to parents, teachers, and health professionals 
who are in a position to promote healthy behaviors.  
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Table 1.1. Characteristics of participants with and without Down syndrome 
 
 Down syndrome (n = 22) Typical development (n = 17) Group difference p ES 
Age (years) 14.96 (1.92) 15.08 (2.12) t (37) = 0.19 .850 .088 
Sex 14 - Male (63.6%) 
8 - Female (36.4%) 
7 - Male (41.2%) 
10 - Female (58.8%) 
X 2 (1,39) = 1.95 .163 .223 
Race/Ethnicity 20 - Caucasian (90.9%)  
1 - African-American (4.55%)  
1 - Hispanic (4.55%) 
17 - Caucasian (100%) X 2 (2,39) = 1.63 .443 .204 
Tanner stage 3.64 (1.09) 3.68 (1.22) t (37) = 0.11 .915 .093 
Height (cm) 145.91 (8.41) 164.68 (11.73) t (37) = 5.82 <.001 1.379 
Weight (kg) 55.69 (10.69) 57.94 (16.76) t (37) = 0.51 .612 .147 
Siblings (#) 2.09 (1.06) 2.29 (1.36) t (37) = 0.52 .603 .206 
Mother’s age (years) 48.77 (6.44) 48.65 (3.67) t (37) = 0.07 .943 .066 
Father’s age (years) 51.14 (7.57) 49.65 (3.28) t (36) = 0.76 .454 .249 
Parent education 3 - HS or GED (13.6%) 
2 - Associates/Vocational (9.1%) 
8 - Bachelors (36.4%) 
8 - Masters (36.4%) 
1 - Doctorate/Professional (4.5%) 
2 - HS or GED (11.8%) 
0 - Associates/Vocational (0%) 
6 - Bachelors (35.3%) 
7 - Masters (41.1%) 
2 - Doctorate/Professional (11.8%) 
X 2 (5,39) = 2.28 .809 .242 
Family income level 1 - <$25,000 (4.5%) 
6 - $50,000-$74,999 (27.3%) 
4 - $75,000-$99,999 (18.2%) 
3 - $100,000-$149,999 (13.6%) 
5 - >$150,000 (22.7%) 
3 - Missing/DNR (13.6%) 
0 - <$25,000 (0%) 
3 - $50,000-$74,999 (17.6%) 
3 - $75,000-$99,999 (17.6%) 
3 - $100,000-$149,999 (17.6%) 
5 - >$150,000 (29.4%) 
3 - Missing/DNR (17.6%) 
X 2 (6,39) = 2.20 .900 .238 
 
Note: Data are Means (Standard Deviations) or Frequencies, n (proportions, %) 
ES = effect size (Cohen’s d for t-tests, Cramer’s V for X 2 tests) 
p < .05, bolded 
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Table 1.2. Group differences in body composition 
 
Body Composition a DS (n=22) TD (n=17) F (1,34) p partial η2 d  b 
CDC growth reference c       
BMI (kg/m2) 25.84 (.807) 21.32 (.921) 13.26 .001 .281 1.06 
BMI %ile 86.47 (4.43) 53.80 (5.05) 23.05 < .001 .404 1.31 
        
DS growth reference d       
BMI %ile 64.09 (4.08) -- -- -- -- -- 
       
DXA (% BF)       
Total % 33.20 (1.80) 25.90 (2.00) 7.26 .011 .176 .692 
Arms % 33.90 (1.80) 26.30 (2.00) 7.65 .009 .184 .603 
Legs % 36.10 (1.60) 29.90 (1.80) 6.25 .017 .155 .570 
Trunk % 32.40 (2.10) 23.30 (2.40) 7.60 .009 .183 .772 
 
MANCOVA controlling for age, sex, and Tanner pubertal stage 
F(6,29) = 4.235, p = .004, Wilks’ Λ = .533, partial η2 = .467 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded 
c CDC growth reference (Kuczmarski et al., 2000) 
d DS growth reference (Zemel et al., 2015) 
p < .05, bolded 
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Table 1.3. Group differences in body composition by sex 
 
Body Composition a DS TD F p η2 d  b 
Male n = 14 n = 7 (1,17)    
CDC growth reference  c       
BMI (kg/m2) 26.76 (1.15) 21.88 (1.64) 5.80 .028 .254 .890 
BMI %ile 90.74 (5.38) 58.44 (7.66) 11.68 .003 .407 1.35 
DS growth reference d       
BMI %ile 74.84 (4.99) -- -- -- -- -- 
DXA (% BF)       
Total % 31.80 (2.30) 23.00 (3.30) 4.74 .044 .218 .879 
Arms % 31.00 (2.20) 21.90 (3.20) 5.40 .033 .241 .929 
Legs % 34.00 (2.20) 26.10 (3.10) 4.37 .052 .205 .862 
Trunk % 31.60 (2.80) 21.00 (4.00) 4.67 .045 .215 .883 
       
Female n = 8 n = 10 (1,14)    
CDC growth reference  c       
BMI (kg/m2) 24.73 (1.10) 20.52 (0.98) 7.82 .014 .358 1.19 
BMI %ile 80.49 (6.47) 49.36 (5.76) 12.32 .003 .468 1.20 
DS growth reference d       
BMI %ile 45.28 (8.08) -- -- -- -- -- 
DXA (% BF)       
Total % 33.60 (2.30) 29.50 (2.10) 1.59 .228 .102 .726 
Arms % 35.40 (2.40) 32.20 (2.10) 0.97 .340 .065 .653 
Legs % 37.00 (1.80) 34.60 (1.60) 0.94 .349 .063 .622 
Trunk % 32.10 (3.00) 26.10 (2.70) 2.07 .172 .129 .777 
 
MANCOVA controlling for age and Tanner pubertal stage 
Male: F(6,12) = 1.66, p = .214, Wilks’ Λ = .546, partial η2 = .454; Female: F(6,9) = 2.73, p = .085, Wilks’ Λ = .355, partial η2 = .645 
a Adjusted group means and standard errors (SE); b Cohen’s d effect size, (unadjusted), d > .80, bolded; c CDC growth reference 
(Kuczmarski et al., 2000); d DS growth reference (Zemel et al., 2015); p < .05, bolded. 
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Table 1.4. Group differences in body fat distribution 
 
Body Fat Ratios a DS (n=22) TD (n=17) F (1,34) p η2 d  b 
Trunk / Total ratio .484 (.013) .402 (.014) 17.66 < .001 .342 1.19 
Legs / Total ratio .357 (.009) .421 (.010) 23.96 < .001 .413 1.32 
Arms / Total ratio .110 (.004) .114 (.004) 0.28 .600 .008 .264 
Arms & Legs / Trunk ratio .993 (.056) 1.37 (.064) 18.84 < .001 .357 1.23 
 
MANCOVA controlling for age, sex, and Tanner pubertal stage 
F(4,31) = 5.68, p = .002, Wilks’ Λ = .577, partial η2 = .423 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded 
p < .05, bolded 
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Table 1.5. Group differences in body fat distribution by sex 
 
Body Fat Ratios a DS TD F p η2 d  b 
Male n = 14 n = 7 (1,17)    
Trunk / Total ratio .495 (.017) .404 (.024) 9.59 .007 .361 1.18 
Legs / Total ratio .345 (.011) .414 (.016) 12.99 .002 .433 1.35 
Arms / Total ratio .109 (.005) .109 (.007) 0.01 .940 .000 .063 
Arms & Legs / Trunk ratio .944 (.068) 1.34 (.098) 10.89 .004 .390 1.26 
       
Female n = 8 n = 10 (1,14)    
Trunk / Total ratio .471 (.019) .397 (.017) 8.49 .011 .377 1.16 
Legs / Total ratio .373 (.015) .431 (.013) 8.41 .012 .375 1.23 
Arms / Total ratio .111 (.006) .118 (.005) 0.74 .404 .050 .314 
Arms & Legs / Trunk ratio 1.05 (.094) 1.41 (.083) 7.89 .014 .360 1.13 
 
MANCOVA controlling for age and Tanner pubertal stage 
Male: F(4,14) = 2.75, p = .070, Wilks’ Λ = .560, partial η2 = .440 
Female: F(4,11) = 2.29, p = .125, Wilks’ Λ = .546, partial η2 = .454 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded   
p < .05, bolded 
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Table 1.6. Differences in proportions of overweight / obese and elevated fat mass 
 
Down syndrome Elevated Body  Fat (DXA) 
Not  
Elevated  
Elevated Body  
Fat (DXA) 
Not  
Elevated 
Obese  
(95th percentile) 27.3% 18.2% 
Overweight 
(85th percentile) 40.9% 31.8% 
Not Obese 13.6% 40.9% Not Overweight 0% 27.3% 
Chi-square X 2 = 2.76, p = .094, V = .354  X 2 = 5.71, p = .017, V = .510 
      
      
Typically Developing Elevated Body  Fat (DXA) 
Not  
Elevated  
Elevated Body  
Fat (DXA) 
Not  
Elevated 
Obese  
(95th percentile) 11.8% 0% 
Overweight 
(85th percentile) 17.6% 0% 
Not Obese 5.9% 82.3% Not Overweight 0% 82.3% 
Chi-square X 2 = 10.58, p = .001, V = .789  X 2 = 17.00, p < .001, V = 1.00 
 
Note: Overweight (85th percentile) and obese (95th percentile) based on CDC growth curves (Kuczmarski et al., 2000); Elevated body 
fatness based on pediatric cut-points (Freedman et al., 2009). 
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Table 1.7. Group differences in physical activity 
 
Physical Activity a DS (n=21) TD (n=17) F (1,33) p η2 d  b 
Sedentary (min/day) 531.74 (9.30) 555.90 (10.64) 2.80 .104 .078 .146 
Light (min/day) 200.99 (7.00) 158.89 (8.01) 14.96 < .001 .312 1.10 
Moderate (min/day) 21.05 (2.42) 25.32 (2.77) 1.29 .264 .038 .098 
Vigorous (min/day) 6.78 (3.25) 20.44 (3.72) 7.32 .011 .182 .617 
MVPA (min/day) 27.83 (5.43) 45.76 (6.21) 4.52 .041 .120 .421 
 
MANCOVA controlling for age, sex, Tanner pubertal stage, and accelerometer wear time. 
MVPA = moderate-to-vigorous physical activity. All physical activity data are minutes per day. 
F(3,31) = 6.75, p = .001, Wilks’ Λ = .605, partial η2 = .395 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded  
p < .05, bolded 
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Table 1.8. Group differences in physical activity by sex 
 
Physical Activity a DS  TD  F  p η2 d  b 
Male (n=14) (n=7) (1,16)    
Sedentary (min/day) 509.69 (11.00) 533.97 (15.88) 1.50 .239 .086 .245 
Light (min/day) 212.87 (8.25) 171.52 (11.90) 7.74 .013 .326 1.15 
Moderate (min/day) 23.46 (2.45) 25.75 (3.53) 0.27 .611 .017 .000 
Vigorous (min/day) 7.58 (3.61) 22.36 (5.21) 5.17 .037 .244 .867 
MVPA (min/day) 31.04 (5.73) 48.12 (8.27) 2.73 .118 .146 .546 
       
Female (n=8) (n=10) (1,13)    
Sedentary (min/day) 553.78 (17.54) 584.48 (15.60) 1.63 .224 .112 .272 
Light (min/day) 192.09 (12.19) 140.53 (10.84) 9.53 .009 .423 .957 
Moderate (min/day) 18.09 (5.10) 24.00 (4.54) 0.72 .413 .052 .284 
Vigorous (min/day) 4.70 (6.32) 19.64 (5.62) 2.98 .108 .186 .453 
MVPA (min/day) 22.79 (11.12) 43.65 (9.89) 1.87 .194 .126 .395 
 
MANCOVA controlling for age, Tanner pubertal stage, and accelerometer wear time 
MVPA = moderate-to-vigorous physical activity. All physical activity data are minutes per day. 
Male: F(3,14) = 3.81, p = .035, Wilks’ Λ = .551, partial η2 = .449 
Female: F(3,11) = 3.59, p = .050, Wilks’ Λ = .505, partial η2 = .495 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded  
p < .05, bolded 
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Table 1.9. Group differences in energy intake and micronutrient distribution  
 
Dietary Intake a DS (n=22) TD (n=17) F (1,34) p η2 d  b 
kcal (per day) 2135.98 (159.06) 2717.79 (181.56) 5.68 .023 .143 .761 
kcal per lean mass (kcal/kg) 63.11 (5.09) 70.23 (5.81) 0.82 .369 .024 .382 
Protein (g/day) 93.59 (7.83) 114.62 (8.93) 3.06 .089 .082 .640 
% Protein 18.10% (0.7%) 16.5% (0.8%) 2.31 .138 .064 .314 
Carbohydrates (g/day) 288.09 (22.23) 363.26 (25.37) 4.84 .035 .125 .688 
% Carbohydrates 53.30% (1.0%) 53.90% (1.1%)  0.16 .635 .005 .032 
Fat (g/day) 70.33 (5.44) 91.78 (6.21) 6.58 .015 .162 .794 
% Fat 29.70% (0.9%) 30.40% (1.0%) 0.23 .635 .007 .125 
Saturated (g/day) 24.76 (2.14) 33.46 (2.44) 7.00 .012 .171 .838 
Monounsaturated (g/day) 24.30 (1.83) 31.35 (2.09) 6.26 .017 .155 .756 
Polyunsaturated (g/day) 13.70 (1.18) 17.93 (1.35) 5.46 .026 .138 .731 
Cholesterol (mg/day) 256.92 (19.68) 282.15 (22.46) 0.70 .410 .020 .249 
Fiber (g/day) 21.60 (1.97) 26.51 (2.25) 2.64 .114 .072 .539 
 
MANCOVA controlling for age, sex, and Tanner pubertal stage 
F(13,22) = 1.98, p = .077, Wilks’ Λ = .461, partial η2 = .539 
a Adjusted group means and standard errors (SE) 
b Cohen’s d effect size (unadjusted), d > .80, bolded  
p < .05, bolded 
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Table 1.10. Group differences in energy intake and micronutrient distribution by sex 
 
Dietary Intake a DS TD F(df) p η2 d  b 
Male (n=14) (n=7) (1,17)    
kcal (per day) 2332.99 (150.61) 2373.52 (214.52) 0.02 .880 .001 .059 
kcal per lean mass (kcal/kg) 63.47 (5.43) 55.88 (7.74) 0.63 .437 .036 .555 
Protein (g/day) 95.27 (6.21) 95.93 (8.85) 0.01 .953 .000 .032 
% Protein 16.50% (0.7%) 16.10% (0.9%) 0.11 .743 .006 .239 
Carbohydrates (g/day) 318.03 (24.71) 326.54 (35.20) 0.04 .847 .002 .101 
% Carbohydrates 53.80% (1.4%) 55.30% (2.0%) 0.38 .545 .022 .353 
Fat (g/day) 78.69 (5.17) 79.13 (7.36) 0.01 .962 .000 .011 
% Fat 30.80% (1.2%) 29.70% (1.8%) 0.26 .616 .015 .258 
Saturated (g/day) 27.26 (2.09) 28.14 (2.98) 0.06 .815 .003 .096 
Monounsaturated (g/day) 27.41 (1.79) 27.56 (2.54) 0.01 .961 .000 .012 
Polyunsaturated (g/day) 15.56 (1.24) 15.32 (1.77) 0.01 .916 .001 .020 
Cholesterol (mg/day) 289.08 (18.63) 241.99 (26.53) 2.07 .168 .109 .720 
Fiber (g/day) 23.69 (2.36) 21.65 (3.37) 0.24 .629 .014 .162 
Female (n=8) (n=10) (1,14)    
kcal (per day) 1789.20 (312.47) 2958.19 (277.98) 7.46 .016 .348 1.19 
kcal per lean mass (kcal/kg) 58.214 (9.50) 83.69 (8.45) 3.83 .070 .215 .997 
Protein (g/day) 84.44 (16.87) 132.66 (15.01) 4.35 .056 .237 .922 
% Protein 19.70% (1.4%) 17.70% (1.2%) 1.16 .300 .076 .698 
Carbohydrates (g/day) 239.49 (40.78) 385.92 (36.28) 6.87 .020 .329 1.16 
% Carbohydrates 53.0% (1.5%) 52.50% (1.3%) 0.06 .814 .004 .698 
Fat (g/day) 57.41 (10.29) 99.26 (9.15) 8.81 .010 .386 1.28 
% Fat 28.60% (1.4%) 30.30% (1.3%) 0.86 .369 .058 .670 
Saturated (g/day) 20.63 (4.07) 36.97 (3.62) 8.60 .011 .380 1.28 
Monounsaturated (g/day) 19.72 (3.45) 33.31 (3.07) 8.29 .012 .372 1.27 
Polyunsaturated (g/day) 10.89 (2.08) 19.39 (1.85) 8.88 .010 .388 1.27 
Cholesterol (mg/day) 198.16 (36.63) 312.22 (32.59) 5.17 .039 .270 .974 
Fiber (g/day) 16.99 (2.95) 30.66 (2.63) 11.42 .004 .449 1.11 
MANCOVA controlling for age and Tanner pubertal stage 
Male: F(5,13) = 2.56, p = .153, Wilks’ Λ = .131, partial η2 = .869; Female: F(2,13) = 0.49, p = .829, Wilks’ Λ = .238, partial η2 = .762 
a Adjusted group means and standard errors (SE)  
b Cohen’s d effect size (unadjusted), d > .80, bolded    
p < .05, bolded 
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Table 1.11. Correlations between body composition and physical activity levels in adolescents with Down syndrome 
 
Variable BMI BMI percentile 
Total 
%BF 
Trunk 
%BF 
Legs 
%BF 
Arms 
%BF 
Sedentary 
PA 
Light  
PA 
Moderate 
PA 
Vigorous 
PA 
MVPA 
BMI − .676* .731* .762* .650* .630* -.259 -.143 -.056 -.335 -.174 
BMI percentile .878* − .643* .648* .622* .636* -.129 .217 .069 -.542* -.170 
Total %BF .784* .671 − .996* .983* .973* .073 -.166 -.288 -.559* -.429 
Trunk % BF .802* .727* .987* − .964* .966* .020 -.180 -.273 -.535* -.408 
Legs %BF .580 .407 .922* .853* − .962* .170 -.142 -.314 -.602* -.464 
Arms %BF .887* .748* .971* .964* .857* − .098 -.162 -.279 -.532 -.412 
Sedentary PA -.521 -.635 -.047 -.132 .229 -.221 − .316 -.060 -.104 -.084 
Light PA .101 .363 .082 .128 .004 .096 -.543 − .750* .193 .607* 
Moderate PA -.322 -.201 -.457 -.432 -.431 -.408 -.418 .762* − .596* .946* 
Vigorous PA -.363 -.320 -.547 -.518 -.527 -.488 -.403 .600 .965* − .824* 
MVPA -.343 -.255 -.501 -.474 -.478 -.447 -.415 .697 .993* .989* − 
 
Note. Values above the diagonal (grey background) represent males with Down syndrome; Values below the diagonal (white 
background) represent females with Down syndrome; BMI = body mass index; %BF = percent body fat; PA = physical activity; 
MVPA = moderate-to-vigorous physical activity. 
*p < .05 
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Table 1.12. Linear regression analyses on total body fat percentage 
 
Variable b SE β p sr 
      
Total Body Fat %  R2 = .400 
Sex .015 .031 .079 .635 .066 
Age .025 .011 .521 .031 .309 
Tanner stage -.048 .016 -.580 .005 -.416 
MVPA (min/day) -.001 .001 -.271 .076 -.251 
kcal / lean mass (kg) .000 .001 .136 .430 .110 
Down syndrome .064 .028 .340 .027 .317 
      
Total Body Fat % for Down syndrome  R2 = .604 
Sex .015 .038 .075 .695 .063 
Age .019 .013 .369 .152 .237 
Tanner stage -.072 .017 -.789 .001 -.667 
MVPA (min/day) -.002 .001 -.302 .095 -.279 
kcal / lean mass (kg) .000 .001 .111 .590 .087 
      
Total Body Fat % for Typically Developing  R2 = .315 
Sex .072 .049 .492 .167 .370 
Age .003 .022 .072 .912 .028 
Tanner stage .008 .034 .125 .826 .056 
MVPA (min/day) -.001 .001 -.263 .414 -.212 
kcal / lean mass (kg) .000 .001 -.060 .870 -.042 
 
Note: Sex = reference is female; Down syndrome = reference is adolescents with Down syndrome;  
MVPA = moderate-to-vigorous physical activity; 
sr = semipartial (part) correlation;  
p < .05, bolded 
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Figure 1.1.  Group differences in body composition 
 
 
 
Estimated marginal means and standard errors of body composition controlling for age, sex, and Tanner pubertal stage 
Typical development (□); Down syndrome (■) 
* p < .05 
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Figure 1.2.  Group differences in body composition by sex 
 
 
Estimated marginal means and standard errors of body composition by sex controlling for age and Tanner pubertal stage. Figure A: 
males, Figure B: females; Down syndrome (■); Typical development (□); males (diagonal); females (horizontal); * p < .05 
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Figure 1.3.  Group differences in body fat distribution 
 
 
 
Estimated marginal means and standard errors of body fat distribution controlling for age, sex, and Tanner pubertal stage 
Typical development (□); Down syndrome (■) 
* p < .05 
 
 
  
47 
Figure 1.4.  Group differences in body fat distribution by sex 
 
 
 
Estimated marginal means and standard errors of body fat distribution by sex controlling for age and Tanner pubertal stage 
Figure A: males, Figure B: females; Down syndrome (■); Typical development (□); males (diagonal); females (horizontal); * p < .05 
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Figure 1.5.  Group differences in prevalence of obesity and elevated fat mass 
 
 
 
Estimated marginal means and standard errors of obesity prevalence controlling for age, sex, and Tanner pubertal stage 
Typical development (□); Down syndrome (■) 
* Group differences, p < .05 
† Difference between BMI and elevated fat mass, p < .05 
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Figure 1.6.  Group differences in physical activity 
 
 
 
Estimated marginal means and standard errors of physical activity controlling for age, sex, Tanner pubertal stage, and Actigraph wear-
time; Typical development (□); Down syndrome (■) 
* p < .05 
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Figure 1.7.  Group differences in physical activity by sex 
 
 
Estimated marginal means and standard errors of physical activity by sex controlling for age, Tanner pubertal stage, and Actigraph 
wear-time; Figure A: males, Figure B: females; Down syndrome (■);Typical development (□); males (diagonal); females 
(horizontal);* p < .05 
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Figure 1.8.  Group differences in energy intake and micronutrient distribution 
 
 
 
Estimated marginal means and standard errors of diet controlling for age, sex, and Tanner pubertal stage 
Typical development (□); Down syndrome (■) 
* p < .05 
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Figure 1.9.  Group differences in energy intake and micronutrient distribution by sex 
 
 
 
Estimated marginal means and standard errors of diet by sex controlling for age and Tanner pubertal stage 
Figure A: males, Figure B: females; Down syndrome (■); Typical development (□); males (diagonal); females (horizontal) 
* p < .05 
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CHAPTER 2 
Diurnal cortisol, obesity, and physical activity in adolescents with and without Down syndrome 
Introduction 
Down syndrome is the most common genetic form of intellectual disability with a 
prevalence estimated at 14.47 per 10,000 live births (Parker et al., 2010).  Individuals with Down 
syndrome typically exhibit phenotypic characteristics including cognitive impairment, unique 
body and facial features, growth stature differences, muscle hypotonia, joint laxity, significant 
delays in motor development, and a variety of medical conditions including congenital heart 
disease (Bull & Committee on Genetics, 2011; Latash, Wood & Ulrich, 2008; Roizen & 
Patterson, 2003).  Life expectancy of persons with Down syndrome has increased substantially 
due to advancements in health care, but morbidity and early mortality remain significantly higher 
than the general population (Bittles, Bower, Hussain & Glasson, 2007; Glasson, Dye & Bittles, 
2014; Torr, Strydom, Patti & Jokinen, 2010).  Addressing secondary health conditions is critical 
to improving long-term health outcomes. 
Obesity is a prevalent health condition among persons with Down syndrome. 
Approximately 55% of youth with Down syndrome are overweight or obese (Rimmer, Yamaki, 
Lowry, Wang & Vogel, 2010) compared to 31% of youth in the general population (Ogden, 
Carroll, Kit & Flegal, 2012; Ogden, Carroll, Kit & Flegal, 2014). The odds of being obese are 
over three times greater for youth with Down syndrome than youth without a disability (Rimmer 
et al., 2010). Estimates of overweight and obesity for adults with Down syndrome in the United 
States continue to increase from childhood levels, ranging from 45% to 72% (Rubin, Rimmer, 
63 
Chicoine, Braddock & McGuire, 1998; Stancliffe et al., 2011).  Smaller studies have reported the 
prevalence of obesity and overweight as high as 89% (Braunschweig et al., 2004; Fujiura, 
Fitzsimons, Marks & Chicoine, 1997; Rimmer & Wang, 2005; Sohler, Lubetkin, Levy, 
Soghomonian & Rimmerman, 2009).  However, the current evidence is limited by the use of 
body mass index (BMI), which may overestimate excess fatness in Down syndrome (Bandini, 
Fleming, Scampini, Gleason & Must, 2012).  Adolescents and adults with Down syndrome have 
been shown to exhibit greater body fat percentages, more total fat mass, less total lean mass, and 
greater abdominal obesity than the general population (Bandini et al., 2012; Baptista, Varela & 
Sardinha, 2005; Gonzalez-Aguero, Ara, Moreno, Vicente-Rodriguez & Casajus, 2011; Guijarro, 
Valero, Paule, Gonzalez-Macias & Riancho, 2008; Loveday, Thompson & Mitchell, 2012; 
Nickerson et al., 2015).  When feasible, measurement of body composition should employ 
technology capable of detecting these systematic differences in body fat topology.  
The foundation for obesity is energy imbalance between caloric intake (i.e. diet) and 
energy expenditure (i.e. physical activity). However, many factors contribute to the development 
of excess fat mass. The hypothalamic-pituitary-adrenal (HPA) axis regulates a variety of 
endocrine processes including energy storage and energy expenditure (Adam & Epel, 2007; 
Bjorntorp, 2001; De Vriendt, Moreno & De Henauw, 2009; Rodriguez et al., 2015). Activation 
of the HPA axis begins with the release of corticotrophin releasing hormone (CRH) from the 
hypothalamus, which stimulates release of adrenocorticotrophic hormone (ACTH) from the 
pituitary gland, which then increases glucocorticoid (i.e. cortisol) secretion from the adrenal 
gland (Adam & Epel, 2007; Bjorntorp, 1996, 2001; De Vriendt et al., 2009). Cortisol can affect 
circulating energy substrate levels in the blood by increasing gluconeogenesis and lipolysis 
(Adam & Epel, 2007; Bjorntorp, 2001; Bjorntorp & Rosmond, 2000). Adipose tissue in the 
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abdominal region, in particular the visceral depot, is especially sensitive to cortisol due to 
increased density of glucocorticoid receptors and regulating enzymes (11β-HSD) in this type of 
adipose tissue. Glucocorticoids, like cortisol, enhance the size and number of fat cells and may 
play a role in the redistribution of adiposity into the visceral (abdominal) depot (Adam & Epel, 
2007; Bjorntorp, 1996, 2001; De Vriendt et al., 2009; Rodriguez et al., 2015).  
Cortisol dysregulation can influence the development of obesity through multiple 
pathways. First, higher cortisol levels (hypercortisolemia) upon waking are commonly associated 
with greater BMI (Bjorntorp, 1996, 2001; De Vriendt et al., 2009), but findings are not 
ubiquitous (Rodriguez et al., 2015).  Second, blunted cortisol reactivity and circadian rhythms 
throughout the day are associated with greater abdominal obesity (Adam & Epel, 2007; 
Bjorntorp, 1996, 2001; De Vriendt et al., 2009).  A blunted or less reactive diurnal cortisol 
pattern likely results in greater total cortisol output across the day.  Third, cortisol is also 
associated with greater insulin and leptin resistance, increased neuropeptide Y release, and 
multiple markers of the metabolic syndrome, thus promoting metabolic dysregulation and 
increased food intake (Adam & Epel, 2007; Bjorntorp, 2001; Nieuwenhuizen & Rutters, 2008; 
Pasquali, Vicennati, Cacciari & Pagotto, 2006).  It has also been suggested that altered cortisol 
regulation and weight gain may perpetuate as a positive feedback loop (Adam & Epel, 2007; 
Anagnostis, Athyros, Tziomalos, Karagiannis & Mikhailidis, 2009; Foss & Dyrstad, 2011).   
HPA axis hormones, including cortisol, are characterized by a circadian diurnal pattern 
with high levels in the morning and decay of output throughout the day (Pasquali et al., 2006). 
Although most research has been conducted in adults, significant associations have been shown 
between aspects of the diurnal cortisol pattern (e.g. morning levels, repeated measures, cortisol 
intercept and slope) and indices of obesity (e.g. BMI, BMI percentile, waist circumference, 
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abdominal fat mass) in children and adolescents.  Multiple studies have identified associations 
suggesting that cortisol levels are higher in individuals with greater adiposity (Barat et al., 2007; 
Guzzetti, Pilia, Ibba & Loche, 2014; Hill, Eisenmann, Gentile, Holmes & Walsh, 2011; Misra et 
al., 2008; Reinehr et al., 2014; Rosmalen et al., 2005; Weigensberg, Toledo-Corral & Goran, 
2008).  It should be noted that these associations are highly variable and many significant 
findings are limited to specific sub-groups within studies (e.g. obese girls; Hill et al., 2011, 
Rosmalen et al., 2005).  Positive associations between cortisol and aspects of elevated body 
fatness appear to be strongest among obese adolescents.  However, two large studies found the 
opposite direction of association with lower cortisol levels associated with higher adiposity 
(Ondrak, McMurray, Hackney & Harrell, 2011; Ruttle et al., 2013).  Independent of BMI or 
adiposity, cortisol has strong positive associations with insulin resistance and other markers of 
metabolic syndrome (Adam et al., 2010; Barat et al., 2007; Guzzetti et al., 2014; Misra et al., 
2008; Prodam et al., 2013; Reinehr et al., 2014; Rubin, McMurray, Hackney & Harrell, 2005; 
Weigensberg et al., 2008), indicating further relevance of this hormonal to overall physical 
health. 
Habitual exercise (e.g. physical activity) can promote health benefits through improving 
adrenal efficiency and lowering basal cortisol levels (Hackney, 2006; Viru & Viru, 2004). 
Evidence is limited in youth, but higher levels of physical activity appear to be associated with 
lower salivary cortisol levels in adolescents and with less cortisol stress reactivity in children 
(Martikainen et al., 2013; Martikainen et al., 2014; Rubin et al., 2005). However, DuBose and 
McKune (2014) found a significant positive association between levels of vigorous physical 
activity with 30-minute post-waking cortisol and an association trending toward significance 
with overall cortisol output. This could indicate that high-intensity physical activity is needed to 
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influence cortisol function. The direction of this relationship is further obscured as both increases 
and decreases in cortisol have been observed in response to exercise interventions in obese 
children (Karacabey, 2009; Ounis et al., 2011) 
There is limited research on cortisol function in persons with Down syndrome (Anneren, 
Sara, Hall & Tuvemo, 1986; Arnell, Gustafsson, Ivarsson & Anneren, 1996; Bricout et al., 2008; 
Hestnes et al., 1991; Murdoch, Giles, Grant & Ratcliffe, 1979), but the most recent evidence 
suggests that persons with Down syndrome may exhibit characteristics of cortisol dysfunction 
that could promote obesity (Bricout et al., 2008). Significantly lower cortisol levels and less 
reactivity to rest and exercise were observed in young adult males with Down syndrome 
compared to controls (Bricout et al., 2008). However, other studies have reported normal cortisol 
values or differences that did not reach statistical significance (Anneren et al., 1986; Arnell et al., 
1996; Hestnes et al., 1991; Murdoch et al., 1979).  
Multiple research questions remain regarding cortisol in Down syndrome: 1) To my 
knowledge, no studies have tracked changes in cortisol across the day in this population, despite 
the known diurnal fluctuation of cortisol (Pasquali et al., 2006). Describing this diurnal pattern 
among individuals with Down syndrome is a first step in examining the association between this 
hormone and health outcomes. An understanding of the cortisol output pattern is also essential to 
contextualize specific tests (e.g. exercise, stress) of cortisol response. 2) Cortisol function has not 
been examined within the scope of obesity in Down syndrome. Given the influence of cortisol on 
body fat (Bjorntorp & Rosmond, 2000), the high rates of obesity and greater fat mass observed in 
adolescents with Down syndrome (Gonzalez-Aguero et al., 2011; Rimmer et al., 2010) may be 
associated with dysregulation of cortisol. Furthermore, only two studies have measured cortisol 
function in youth with Down syndrome (Anneren et al., 1986; Arnell et al., 1996), both with 
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measures with limited generalizability. Growth velocity in adolescents with Down syndrome can 
be 25% to 50% lower than in typically developing adolescents (Cronk et al., 1988), putting 
adolescents with Down syndrome at increased risk for obesity during this period (van Gameren-
Oosterom et al., 2012). Changes in endocrine function during this period may also be important 
to understanding the greater rates of obesity in Down syndrome (Alberga, Sigal, Goldfield, Prud' 
homme & Kenny, 2012; Daniels et al., 2005).  More cortisol research is needed, particularly in 
adolescents during the sensitive period of puberty, to understand the developmental nature of this 
obesogenic hormone. 3) Physical activity levels are often lower among youth with Down 
syndrome compared to peers without disabilities (Pitetti, Baynard & Agiovlasitis, 2013), 
although more objective physical activity data are needed. While the association between BMI 
and physical activity is weak and non-significant among youth with Down syndrome (Esposito, 
MacDonald, Hornyak & Ulrich, 2012; Izquierdo-Gomez et al., 2015; Shields, Dodd & Abblitt, 
2009), the joint effects of adiposity and physical activity may have implications for cortisol 
function.  
  The purpose of this study was to identify clinical differences in diurnal cortisol patterns, 
adiposity, and physical activity levels in adolescents with Down syndrome and with typical 
development. Furthermore, this study sought to examine the independent and interactive 
associations between Down syndrome, elevated body fatness, and engagement in physical 
activity with diurnal cortisol function. These associations may be clinically relevant to 
understanding the potential contributions of cortisol dysregulation to the high rates of obesity in 
this at-risk population. 
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Methods 
Participants 
Participants were adolescents with Down syndrome or typical development between 12 
and 18 years old and Tanner stages III to V (Marshall & Tanner, 1969, 1970).  Exclusion criteria 
to participation included a) documented history of hormonal insufficiency (e.g. hypothyroid); b) 
use of medication that could alter metabolic functions (e.g. prednisone, central nervous system 
stimulants, growth hormone, thyroid hormone); c) comorbid disease (e.g. diabetes); d) 
contraindication limiting ability to safely perform physical exercise (e.g. cardiac insufficiency); 
and/or e) dual disability diagnosis (e.g. autism).  Participants were recruited through Down 
syndrome parent support groups in Michigan and northern Ohio, family referrals, local school 
districts, and from previous study participants.  Groups of adolescents with and without Down 
syndrome were similar on sex, age, and Tanner pubertal stage (p > .05). Matching groups on 
cognitive function or other developmental indices was considered, but would have resulted in a 
pre-pubertal control group with different hormone profiles. 
All methods and procedures for the study were approved by the Institutional Review 
Board of the University of Michigan Medical School. All parents provided written informed 
consent documents while participants completed written or verbal assent prior to initiating the 
study.  Adult participants (e.g. 18 years old) independently provided written informed consent. 
However, parents of adult participants with Down syndrome also provided written consent.   
 Procedures 
Phases.  Each participant completed the study in two phases.  Participants first completed 
a clinical visit at the Michigan Clinical Research Unit at the University of Michigan Hospital. 
The clinical visit included the informed consent process, measurement of body composition 
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through standard anthropometry and a single dual-energy X-ray absorptiometry (DXA) scan, and 
parental questionnaires.  Following the clinical visit, each participant provided a total of nine 
saliva samples (3 times per day for 3 days) to measure cortisol patterns and one week of 
accelerometry to estimate habitual physical activity levels.  Participants and parents were trained 
in the saliva sampling and accelerometer procedures during the clinical visit.   
Demographics.  Each participant’s parent completed a proprietary demographic survey 
with assistance from the participant. Proxy reporting was employed to reduce response bias due 
to intellectual disabilities (Emerson, Felce & Stancliffe, 2013). The survey documented the age, 
race and ethnicity, current medication use, and comorbidities of participants. 
Puberty.  Tanner’s stages of pubertal development were used to describe the 
maturational state of participants (Marshall & Tanner, 1969, 1970).  Pubertal stage was estimated 
via parental report using schematic line drawings (Morris & Udry, 1980).  Strong correlations (r 
> 0.60) have been shown in Tanner assessment between line drawings and physical exams 
(Morris & Udry, 1980). Parental reports can provide an acceptable estimate of pubertal stage 
(Coleman & Coleman, 2002)  and are less invasive and stressful than traditional physical 
assessment. Minimizing stress, which directly influences cortisol levels (Bjorntorp, 2001; De 
Vriendt et al., 2009), was critical to not skew study outcomes. Tanner stage was calculated as the 
average of reported stages for each participant (i.e. females: breast and pubic hair development; 
males: genital and pubic hair development).  All participants were adolescents in Tanner stages 
III to V. 
Anthropometry.  All anthropometric measurements were conducted according to 
established guidelines (Lohman, Roche & Martorell, 1988). Height was measured to the nearest 
0.1 cm with a stadiometer (S-214; SECA, Hanover, MD).  Weight was measured to nearest 0.01 
70 
kg with a digital scale (H-349KL; Health O Meter, McCook, IL). Measurements were taken in 
duplicate, with a third trial taken if measures differed by more than 0.5 cm or 0.5 kg, 
respectively.  The average of all trials were used to calculate BMI (kg/m2) and BMI percentile 
from the CDC growth reference (Kuczmarski et al., 2000). Participants with Down syndrome 
were also categorized based on population-specific BMI-for-age curves (Zemel et al., 2015). 
Dual-Energy X-Ray Absorptiometry. Each participant completed one DXA scan 
(Lunar Prodigy Advance [DPX-IQ 240] densitometer; GE Healthcare, Madison, WI). DXA 
scans provided a three-component (fat mass, lean body mass, and bone mass) analysis of body 
composition.  This technology is cost-effective, time-efficient, and has minimal risk (0.37 μSv 
radiation), yet is highly correlated with advanced imaging techniques (e.g. computerized 
tomography scan, magnetic resonance imaging) and reliable (ICC ≥ 0.97) in pediatric 
populations (Albanese, Diessel & Genant, 2003; Kendler et al., 2013; Margulies et al., 2005). 
The Lunar Prodigy was calibrated daily according to manufacturer’s instructions using a 
standardized block. 
Participants wore light clothing and were positioned in a supine position with hands by 
the sides in a neutral position. A warm blanket was used to assist the participant with 
maintaining position during the scan, if needed. Pediatric software (enCore 14.0; GE Healthcare, 
Madison, WI) estimated body fat percentage for total body and regional segments (i.e. trunk, 
legs, and arms). Obesity was classified based on age- and sex-specific cut-points for elevated 
body fat percentage  (Freedman et al., 2009). 
Saliva Sampling. To measure diurnal patterns in cortisol, each participant provided three 
saliva samples per day for three consecutive days (nine samples total). Salivary cortisol is highly 
correlated with free serum cortisol (Dorn, Lucke, Loucks & Berga, 2007) and is the most 
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common approach to naturalistic cortisol measurement. The three daily samples were scheduled 
respective to the participant’s waking times on that day.  Sampling times included: 1) 
immediately after waking; 2) an afternoon measurement occuring when the participant returned 
home from school or daily activity (approximately 3:00 to 5:00pm); and 3) immediately prior to 
bedtime. These timepoints were consistent with methodology for diurnal salivary cortisol 
measurement (Hoyt et al., 2014; Keiver, Bertram, Orr & Clarren, 2015; Ruttle et al., 2013; 
Shirtcliff et al., 2012).  Participants were instructed not to eat, drink, or brush their teeth in the 30 
minutes before each sample. The participant’s wake time, bedtime, and saliva sample collection 
times were reported on a brief questionnaire. 
Saliva was collected with an oral swab (Salimetrics, State College, PA). Participants 
placed the swab underneath the tongue to absorb saliva for 3 to 5 minutes while seated.  The 
saturated swab was then stored in an individually-numbered polypropylene vial and frozen for 
storage.  Cortisol concentration (µg/dL) was measured using enzyme-linked immunosorbent 
assay (ELISA) techniques with the Expanded High Range Sensitivity Salivary Cortisol Enzyme 
Immunoassay Kit (Salimetrics, State College, PA). The assay had a lower limit of sensitivity 
(minimum detectable concentration) of 0.007 μg/dL (Shirtcliff, Granger, Schwartz & Curran, 
2001) and acceptable inter-assay (5.53%) and intra-assay (5.14%) coefficients of variance 
(%CV). These indices of precision and repeatability are acceptable based on recommended 
guidelines for bioassays (Reed, Lynn & Meade, 2002).  
Physical Activity. Each participant wore an Actigraph GT3X+ (Pensacola, FL) triaxial 
accelerometer at the waist during waking hours for seven days to measure physical activity 
levels. Criteria for minimum wear time included 10 hours per day for at least 4 days of the 7-day 
period, including at least one weekend day (Cain, Sallis, Conway, Van Dyck & Calhoon, 2013).  
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Data were assessed for non-wear time using validated algorithms (Choi, Liu, Matthews & 
Buchowski, 2011) and classified into physical activity intensity categories from Evenson et al. 
(2008) based on counts per minute (cpm) using ActiLife 6 software (v6.9.5; Actigraph, 
Pensecola, FL).  Physical activity was operationalized as minutes per day of moderate-to-
vigorous physical acitivty (MVPA; ≥ 2296 cpm).  Participants were divided post hoc into groups 
based on whether or not they averaged 30 minutes of MVPA per day. The threshold of 30 
minutes was selected due to low levels of physical activity within the sample. This limited the 
ability to group participants based on meeting the current World Health Organization 
recommendation of 60 minutes of MVPA per day (World Health Organization, 2010). 
Statistical Analysis 
All statistical analyses were conducted using SPSS 22.0 (IBM Corp., Armonk, NY) with 
an a priori α of 0.05.  Characteristics of the sample were described using independent t-tests for 
continuous data and Pearson’s Chi-square (X 2) tests for dichotomous data with effect sizes (i.e. 
Cohen’s d). 
To be included in analyses, a participant needed to have at least 5 valid cortisol 
measurements across 2 or more days.  A total of 286 cortisol data points from the 33 participants 
were included in analyses, with 11 (3.7%) data points missing. Cortisol data were not normally 
distributed, thus all analyses were performed on logarithmically transformed cortisol values. 
However, figures were designed with raw cortisol values to aid in interpretation. 
 Linear Mixed Modeling (LMM) techniques were employed to examine associations 
between Down syndrome, adiposity, and physical activity on the diurnal pattern of cortisol.  This 
approach is relevant as LMM allows for random parameters estimates, is not limited by non-
independent (e.g. repeated) observations, and does not require an equal number of data points, 
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thus accommodating missing values.  All models include random intercepts to estimate cortisol 
concentration at wakening and repeated time parameters to account for decreases in cortisol 
across the day.  Sex and hours since waking were included as a covariates in all models. Age and 
Tanner pubertal stage were also examined as covariates, but neither factor was statistically 
significant in any models and both were removed in favor of parsimony and maximizing 
statistical power. Each model examined specific associations with diurnal cortisol pattern: Model 
1) presence of Down syndrome; Model 2) elevated body fat and interaction with Down 
syndrome; Model 3) engaging in more MVPA per day and interaction with Down syndrome; and 
Model 4) interaction between Down syndrome, adiposity, and MVPA. Models 2 through 4 were 
then repeated with separate analyses for adolescents with and without Down syndrome.  
Results 
The final sample included participants with valid cortisol data and all covariates (n = 33). 
Characteristics of the sample are presented in Table 2.1. Groups had similar compositions based 
on age, sex, and Tanner pubertal stage (p > .05).  
Table 2.2 shows the group differences in body composition.  Large differences were 
observed across all measures of body composition, except for weight, t(31) = -.255, p = .801, d = 
.090. Differences in total body fat percentage approached statistical significance, t(31) = 2.03, p 
= .051, d = .676. Adolescents with Down syndrome had higher body fat percentage in the trunk 
region (32.33%) than with typical development (23.52%), t(31) = 2.44, p = .020, d = .792; and a 
higher ratio of truncal fat to total fat (M = 0.49, SD = .13) than with typical development (M = 
0.40, SD = .09), t(31) = 4.52, p < .001, d = 1.24. The proportion of overweight, defined as ≥85th 
percentile on CDC growth curves (Kuczmarski et al., 2000), was significantly greater among 
adolescents with Down syndrome (81.2%) than with typical development (17.6%), X 2(1) = 
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13.35, p < .001, d = 1.25. However, 62.5% of adolescents with Down syndrome were below the 
75th percentile on BMI-for-age curves specific to youth with Down syndrome (Mpercentile = 67.66, 
SD = 22.19) (Zemel et al., 2015). This indicates that despite large differences in BMI compared 
to controls, the sample with Down syndrome adequately represents the population.  
Table 2.3 shows the group differences in physical activity level between groups. No 
differences in MVPA were observed between groups, t(31) = -1.32, p = .196, d = .455. Physical 
activity levels were very low in the sample (M = 35.99 minutes/day, SD = 28.12). Few 
participants met the recommended guidelines of 60 minutes of MVPA per day (typical 
development = 17.6%, Down syndrome = 0.0%) and only half of participants averaged 30 
minutes (typical development = 47.0%, Down syndrome = 50.0%). 
Cortisol followed the expected diurnal pattern with high levels in the morning and low 
levels at night. LMM (Model 1) presented in Table 2.4 showed a significant linear decrease in 
log-cortisol across hours of the day (b = -0.11, p < .001). This corresponds to an average 
decrease in cortisol concentration of 0.026 μg/dL per hour. Adolescents with Down syndrome 
exhibited higher morning cortisol concentration (0.36 μg/dL) than adolescents with typical 
development (0.34 μg/dL). However, there were not significant differences in log-cortisol at the 
intercept (b = -0.22, p = .171) or in slope across time (b = 0.70, p = .363). Diurnal cortisol 
trajectories across the day are shown in Figure 2.1. The random intercept and within-subject 
variance of repeated measures were significant (p < .001), justifying the inclusion of random 
effects in the model.  
The LMM analyses for Models 2 and 3 are presented in Table 2.5 and Table 2.6, 
respectively. A significant linear decrease in log-cortisol was observed across hours in all models 
(p < .001). Model 2 examined the interaction between Down syndrome and elevated body fat 
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percentage (Freedman et al., 2009). No significant differences were observed at the intercept 
between adolescents with and without Down syndrome (b = -0.16, p = .365) or elevated body 
fatness (b = 0.14, p = .461). Interactions between the presence of Down syndrome and body 
fatness across the day were not statistically significant (p > .500). Model 3 examined the 
interaction between Down syndrome and participating in 30 or more minutes of MVPA per day. 
Significant differences at the intercept were not observed between adolescents with and without 
Down syndrome (b = -0.23, p = .158) nor between adolescents that did or did not meet 30 
minutes of MVPA per day (b = -0.17, p = .296). Interactions in slope between disability and 
MVPA groupings were also not significant (p > .100).  
Model 4 examined the interaction between all groupings (Table 2.7). A significant linear 
effect across time points (b = -0.43, p = .022) was observed independent of the effect of hours 
since waking (p < .001). While no group differences in log-cortisol were observed between 
Down syndrome, body fatness, or MVPA groups at the intercept (p > .300), multiple significant 
interactions were observed across time. Compared to adolescents in the reference group (i.e. 
adolescents with Down syndrome, normal body fat percentage, and < 30 minutes of MVPA per 
day), log-cortisol slope was significantly higher in adolescents with Down syndrome, with 
normal body fat, and higher MVPA (b = 0.59, p < .001), and typically developing adolescents 
with normal body fat and either low MVPA (b = 0.21, p = .050) or higher MVPA (b = 0.27, p = 
.034). The difference in slope for adolescents with Down syndrome, elevated body fat, and low 
MVPA also trended toward statistical significance (b = 0.19, p = .091). Diurnal cortisol patterns 
between groups by Down syndrome, body fatness, and MVPA are shown in Figure 2.2. 
Significant pairwise comparisons were observed across multiple time points within adolescents 
with Down syndrome (p < .05), but not typical development. In all models, the random intercepts 
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and within-subject variances were significant (p < .001), again reinforcing the need to account 
for random effects in diurnal cortisol. 
Discussion 
The current study examined whether diurnal cortisol pattern was associated with the 
presence of Down syndrome, adiposity, and levels of physical activity. To my knowledge, this is 
the first study to track diurnal cortisol in adolescents with Down syndrome. Previous studies in 
persons with Down syndrome have examined cortisol in single measure (Anneren et al., 1986; 
Arnell et al., 1996; Hestnes et al., 1991; Murdoch et al., 1979), during stress tests (Murdoch et 
al., 1979), and during periods of rest and exercise (Bricout et al., 2008). Examining the diurnal 
cortisol patterns through multiple measurements across the day may provide additional 
information about HPA axis activity and its associations with obesity.  
The main finding of this study is that adolescents with Down syndrome do not appear to 
have different diurnal cortisol trajectories than adolescents with typical development. A diurnal 
pattern with high morning cortisol levels and a log-linear decrease in concentration across the 
day was observed for both groups. This pattern is consistent with the expected nature of this 
hormone (Pasquali et al., 2006). Cortisol levels were higher in adolescents with Down syndrome 
at each time point compared to adolescents with typical development. However, neither the 
intercept (p > .100) nor slope (p > .300) were statistically different between groups. The lack of 
significant group differences is consistent with studies utilizing single measurements of cortisol 
(Anneren et al., 1986; Arnell et al., 1996; Hestnes et al., 1991; Murdoch et al., 1979).  However, 
the observed diurnal pattern, characterized by a significant negative slope across hours (p < 
.001), confirms that repeated measurements are required to properly describe cortisol function. 
While Bricout et al. (2008) found lower cortisol levels during rest and a blunted response to 
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exercise among young adult males with Down syndrome, it remains unclear how these short 
periods of time fit into the diurnal cortisol pattern. Absolute differences in cortisol concentration 
between adolescents with Down syndrome and typical development in the present study, 
regardless of statistical significance, were larger in the morning than at other time points. The 
significant differences observed by Bricout et al. (2008) all occurred in the morning, but the time 
from waking was not reported. Thus, the discrepancy in cortisol patterns between the two studies 
may be due to differences in the scope of measurement.  The current study included adolescents 
while Bricout et al. (2008) included young adults suggesting there may also be systematic 
differences due to age or pubertal status (De Vriendt et al., 2009; Tsai, Seiler & Jacobson, 2013).   
Differences in cortisol pattern began to emerge when accounting for body fatness and 
engagement in physical activity. Model 4 compared adolescents with Down syndrome who had 
normal body fat percentages, but did not average at least 30 minute of MVPA per day to other 
combinations of these factors. Significant (or trending towards significant; p < .10) differences 
were observed within adolescents with Down syndrome based on both physical activity and 
elevated body fatness. Typically developing adolescents with normal body fatness were 
significantly different than the reference group, regardless of physical activity participation. The 
general pattern within each group was that cortisol was lower among adolescents with normal 
body fat and/or with higher levels of physical activity. Given these interactions, the high 
prevalence of overweight in adolescents with Down syndrome in the sample may be affecting the 
ability to identify differences between groups in Model 1. 
While significant associations have been shown in typically developing children and 
adolescents between diurnal cortisol patterns and indices of obesity (Barat et al., 2007; Hill et al., 
2011; Ruttle et al., 2013) or physical activity (DuBose & McKune, 2014; Martikainen et al., 
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2014), the direction of these associations are variable. Most studies have found positive 
associations between cortisol and adiposity, particularly in youth with obesity (Barat et al., 2007; 
Guzzetti et al., 2014; Hill et al., 2011; Misra et al., 2008; Reinehr et al., 2014; Rosmalen et al., 
2005; Weigensberg et al., 2008).  The current study is consistent with a positive association 
between cortisol and adiposity.  The high level of abdominal obesity among adolescents with 
Down syndrome was also consistent with the relationship between cortisol and visceral fat (Barat 
et al., 2007; Misra et al., 2008).  Conversely, Ruttle et al. (2013) and (Ondrak et al., 2011) found 
strong negative associations between cortisol and BMI.  These differences may be due to 
differences in the measurement of adiposity. 
Similar variability in the existing literature is present for the relationship between cortisol 
and physical activity. DuBose and McKune (2014) found that physical activity was positively 
associated with cortisol levels in girls, but only the association between vigorous physical 
activity and 30-minute post waking cortisol was statistically significant. Conversely, Martikainen 
et al. (2014) found a negative association between cortisol and both overall physical activity and 
vigorous physical activity, but this was only statistically significant in girls. The current study 
suggests a negative association, with lower cortisol levels in adolescents who participate in more 
MVPA. It should be noted, that an interesting relationship appears in adolescents with Down 
syndrome. Morning cortisol was significantly higher in those with more physical activity, but the 
slope was much steeper resulting in significantly lower levels at night. This is yet another 
example of how cortisol measurement (e.g. one time point vs. diurnal pattern) can affect 
interpretations. 
As seen in Figure 1, one group within adolescents with Down syndrome appears to 
behave differently (solid black line: Down syndrome with normal body fatness and met 30 
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minutes of MVPA). Cortisol levels were significantly higher and flatter (p < .001) in this group, 
despite having less body fat and more physical activity. However, this sub-group includes only 
two participants; both are males in Tanner stage IV. Males have been shown to produce more 
cortisol than females and cortisol production is positively associated with Tanner staging (Tsai et 
al., 2013). This may explain the phenomenon within this sample and would suggest that this 
group may not be representative of adolescents with Down syndrome who have favorable 
adiposity and physical activity characteristics.  However, Hill, Eisenmann, Holmes and Heelan 
(2010) also found high levels of cortisol among a small group of children with normal body 
composition that was not congruent with other findings. 
A secondary finding of this study was the differences in body composition between 
adolescents with Down syndrome and typical development. Compelling evidence has 
consistently shown that youth with Down syndrome experience obesity at higher rates than the 
general population (Bandini et al., 2012; Gonzalez-Aguero et al., 2011; Izquierdo-Gomez et al., 
2015; Rimmer et al., 2010). The current study also found a significantly higher prevalence of 
overweight (81.2%) among adolescents with Down syndrome (p < .001, d = 1.25). Statistically 
significant differences were observed between groups for both BMI percentile (p < .001, d = 
1.31) and percent body fat from the DXA scan (p = .051, d = 0.68). The magnitude of difference 
was considerably smaller with body fat percentage, further suggesting that BMI may 
overestimate the extent of excess fatness in youth with Down syndrome (Bandini et al., 2012). 
Body fat distribution was also significantly different in adolescents with Down syndrome. A 
higher proportion of body fat was stored in the trunk region (p < .001), consistent with findings 
from Gonzalez-Aguero et al. (2011). Greater fat mass in the abdominal region is also consistent 
with dysregulation of the HPA axis. Cortisol levels are associated with fat mass in the abdomen, 
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particularly in overweight and obese youth, when measured through waist circumference or 
DXA (Barat et al., 2007; Hill et al., 2011). These differences in body fat are important to obesity 
research in Down syndrome as they identify the abdomen as a particularly useful area for clinical 
measurement, reinforce the limitations of BMI for understanding obesity in this population, and 
illustrate the additional information we can ascertain from DXA. While DXA scanners have 
considerable costs and are not feasible for field research, the additional measurement potential is 
worthwhile when possible.  
The lack of participation in physical activity in youth with Down syndrome is 
problematic. Adolescents with Down syndrome averaged approximately 36 minutes of MVPA 
per day, with only 50% averaging more than 30 minutes per day during the measurement week. 
No participants with Down syndrome met the recommended guidelines of 60 minutes per day 
(World Health Organization, 2010). However, it should be noted that physical activity levels in 
the control group with typical development (42.20 minutes per day) were also below 
recommendations. Previous studies have found similarly low levels of physical activity in Down 
syndrome (Pitetti et al., 2013), but these results are not ubiquitous. For example, Esposito et al. 
(2012) found only 20.6% of youth with Down syndrome met physical activity guidelines, with a 
strong negative association between MVPA and age. However, other studies have reported levels 
of MVPA that were near or exceeding the guidelines of 60 minutes of MVPA per day 
(Izquierdo-Gomez et al., 2015; Shields et al., 2009). Still, less than half of youth with Down 
syndrome (42.1%) consistently met the 60-minute recommendation across a week (Shields et al., 
2009). Differences in cut-points used to classify physical activity intensity across studies may 
explain some of the variation in reported MVPA levels. It should be noted that the validity of 
these cut-points for individuals with Down syndrome are highly questionable due to differences 
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in energy expenditure (Agiovlasitis, Motl, Foley & Fernhall, 2012), thus, reported levels of 
MVPA should be viewed cautiously.  Validated cut-points specific to persons with Down 
syndrome for use in physical activity epidemiology research are of great need (Pitetti et al., 
2013). 
 The physical activity levels reported in the current study are among the lowest reported 
for youth with Down syndrome (Pitetti et al., 2013). Coupled with the high rates of obesity and 
elevated fat mass, there are evident health disparities with the sample. Health promotion and 
direct intervention efforts are clearly needed for this at-risk population (Pitetti et al., 2013; 
Rimmer et al., 2010; Shields et al., 2009). Study designs that allow researchers to examine 
relationships between health behaviors and health conditions at baseline before intervening to 
increase healthy behaviors may be particularly beneficial.  
Despite the high prevalence of excess adipose tissue, additional health conditions 
including metabolic syndrome, type II diabetes, and hypertension are surprisingly absent in 
Down syndrome (De Winter, Bastiaanse, Hilgenkamp, Evenhuis & Echteld, 2012; Draheim, 
McCubbin & Williams, 2002; Real de Asua, Parra, Costa, Moldenhauer & Suarez, 2014).  The 
mechanism behind this phenomenon is currently unknown, but sympathetic hypoactivity and 
endocrine balances unique to Down syndrome have been proposed (Adelekan, Magge, Shults, 
Stallings & Stettler, 2012; Agiovlasitis et al., 2010; Corsi et al., 2009).  Even with the lack of 
metabolic and atherosclerotic complications, obesity remains a serious health issue for persons 
with Down syndrome due to detrimental effects on mobility, independent living, community 
participation, and quality of life (Rimmer & Yamaki, 2006). 
 The current study has a number of limitations that are important to consider when 
interpreting these results. First, the current sample size is small and limits the type of analyses 
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that could be conducted. However, statistically significant results were obtained. The LMM 
procedures were able to converge with the variance components covariance structure and were 
appropriate for the data. Schwarz’s Bayesian Criterion (BIC) ranged from 265.03 to 608.24. The 
smallest BIC value observed for Model 4 (BIC = 265.03), represented the best fit. Interpretation 
of Model 4 is limited by the small number of participants in each group. This issue is illustrated 
by the small subgroup with Down syndrome, normal body fat, and ≥ 30 minutes of MVPA per 
day. While the results of this study are novel, it is critical to reexamine these research questions 
with a sample capable of producing balanced subgroups. Second, the current sample had a 
greater proportion of overweight participants in the group with Down syndrome. Analyses with 
equal representation in BMI obesity status between groups may alter results. However, matching 
groups for obesity status, whether through BMI or body fat (Gonzalez-Aguero et al., 2011), is 
only possible with a leaner group of adolescents with Down syndrome and a more overweight 
group of adolescents with typical development. Such a sample would then have questionable 
generalizability to either population. If possible, future studies may attempt to recruit unique 
equally distributed sample of adolescents with and without Down syndrome as well as with and 
without obesity to examine the independent and joint effects of these factors. Third, physical 
activity levels were very low among both groups. Low physical activity levels could potentially 
affect the observed associations.  The lack of validated cut-points for youth with Down 
syndrome continue to limit the interpretation of physical activity data. Finally, this research was 
cross-sectional and thus cannot infer or establish causation. Despite these limitations, the current 
results provide useful preliminary evidence to guide future research. 
An extensive body of evidence from the general population supports the association 
between cortisol dysfunction and obesity (Adam & Epel, 2007; Barat et al., 2007; Bjorntorp & 
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Rosmond, 2000; De Vriendt et al., 2009; Hill et al., 2011; Pasquali et al., 2006; Rodriguez et al., 
2015; Ruttle et al., 2013). Physical activity appears to be a health behavior capable of modifying 
hormonal patterns (Aucouturier et al., 2013; De Vriendt et al., 2009; DuBose & McKune, 2014; 
Martikainen et al., 2014), but more prospective studies are needed. To my knowledge, this is the 
first study to describe the diurnal pattern of cortisol and demonstrate associations with adiposity 
and physical activity in Down syndrome. A larger study is needed to better analyze this 
relationship, but these preliminary results justify the continuation of this research. Understanding 
the unique factors that contribute to health disparities in obesity among individuals with Down 
syndrome is a critical step in efforts to design and implement health promotion interventions.    
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Table 2.1.  Characteristics of participants with and without Down syndrome 
 
Demographics 
Total 
(n=33) 
Down syndrome 
(n=16) 
Typically developing 
(n=17) p d
 
Female, n(%) 16 (48.5%) 6 (38.0%) 10 (59.0%) .221 a .420 
Age (years) 14.91 (1.94) 14.72 (1.78) 15.08 (2.12) .593 b .190 
Tanner (III-V) 3.62 (1.14) 3.56 (1.09) 3.68 (1.22) .780 b .099 
Caucasian, n(%) 32 (97.0%) 15 (93.8%) 17 (100%) .295 a .359 
 
 
Note: Values are Mean (Standard Deviation) unless otherwise noted. Abbreviations: n = frequency, % = proportion of column sample, 
d = Cohen’s d effect size 
a Pearson’s chi-square test (X 2) 
b Independent samples t-test (t) 
* p < .05, bolded 
† p < .10, italicized 
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Table 2.2. Group comparisons for body composition 
 
Body Composition 
Total 
(n=33) 
Down syndrome 
(n=16) 
Typically developing 
(n=17) p d
 
Weight (kg) 57.34 (13.61) 56.70 (9.98) 57.94 (16.31) .801 b .090 
Height (cm) 155.95 (13.40) 146.62 (7.99) 164.68 (11.42) <.001 b* 1.33 
BMI (kg/m2) 23.59 (4.81) 26.34 (3.98) 21.01 (4.05)   .001 b* 1.09 
BMI %ile (CDC) 70.47 (27.72) 89.58 (10.69) 52.49 (26.79) <.001 b* 1.32 
BMI%ile (DS) -- 67.66 (22.19) -- -- -- 
Total Percent Body Fat 29.52% (9.6%) 32.88% (10.8%) 26.35% (7.4%)   .051 b† .676 
Trunk %BF 27.92 (11.45) 32.59 (12.51) 23.52 (8.55)   .020 b* .792 
Legs %BF 32.79 (8.90) 35.18 (9.97) 30.55 (7.36) .137 b .521 
Arms %BF 29.84 (10.24) 32.69 (10.60) 27.16 (9.43) .123 b .540 
Elevated Body Fat, n(%) 13 (39.4%) 10 (62.5%) 3 (17.6%)   .008 a* .904 
 
 
Note: Values are Mean (Standard Deviation) unless otherwise noted. Abbreviations: n = frequency, % = proportion of column sample, 
BMI = body mass index, %ile = BMI percentile, CDC = Centers for Disease Control growth chart (Kuczmarski et al., 2000), DS = 
Down syndrome growth chart (Zemel et al., 2015), %BF = percent body fat, d = Cohen’s d effect size 
a Pearson’s chi-square test (X 2) 
b Independent samples t-test (t) 
* p < .05, bolded 
† p < .10, italicized 
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Table 2.3. Group comparisons for physical activity 
 
Physical Activity 
Total 
(n=33) 
Down syndrome 
(n=16) 
Typically developing 
(n=17) p d
 
Sedentary (min/day) 549.61 (62.77) 550.74 (56.33) 548.55 (70.02) .922 b .034 
Light (min/day) 184.57 (53.89) 221.30 (42.76) 149.99 (38.41) <.001 b* 1.32 
Moderate (min/day) 23.38 (11.39) 23.18 (8.67) 23.57 (13.75)  .923 b .034 
Vigorous (min/day) 13.30 (17.70) 7.64 (4.84) 18.63 (23.29)   .074 b† .621 
MVPA (min/day) 36.68 (27.81) 29.41 (13.30) 42.20 (36.49) .246 b .455 
≥ 30 min/day MVPA, n(%) 16 (48.5%) 8 (50.0%) 8 (47.1%) .866 a .058 
≥ 60 min/day MVPA, n(%) 3 (9.1%) 0 (0%) 3 (17.6%)   .078 a† .604 
 
 
Note: Values are Mean (Standard Deviation) unless otherwise noted. Abbreviations: n = frequency, % = proportion of column sample, 
BMI = body mass index, MVPA = moderate to vigorous physical activity, min/day = minutes per day, d = Cohen’s d effect size 
a Pearson’s chi-square test (X 2) 
b Independent samples t-test (t) 
* p < .05, bolded 
† p < .1 
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Table 2.4.  Linear mixed model on diurnal cortisol between adolescents with and without Down syndrome (Model 1) 
 
Dependent Variable: Ln Cortisol (μg/dL) Model 1  
Predictor b p 
Intercept -0.781 <.001* 
Fixed effects   
Down syndrome (DS) REF  
Typical development (TD) -0.220 .171 
Sex 0.077 .435 
Hours -0.111 <.001* 
Time -0.153 .376 
DS * Time 0.070 .363 
Random Effects   
var (morning) 0.158 <.001* 
var (afternoon) 0.276 <.001* 
var (night) 0.493 <.001* 
Intercept 0.142 <.001* 
 
Note: DS = Down syndrome ; TD = typical development Sex = reference is female. 
*  p < .05, bolded 
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Table 2.5.  Linear mixed model on diurnal cortisol, Down syndrome, and elevated fat mass (Model 2) 
 
Dependent Variable: Ln Cortisol (μg/dL) Model 2a  Model 2b  Model 2c 
 Total  Down syndrome  Typical Development 
Predictor b p  b p  b p 
Intercept -0.856 <.001*  -0.710 .008*  -1.237 <.001* 
Fixed effects         
Down syndrome (DS) REF   -- --  -- -- 
Typical development (TD) -0.163 .365  -- --  -- -- 
Sex 0.095 .349  -0.048 .722  0.257 .081† 
Hours -0.108 <.001*  -0.100 .002*  -0.122 .001* 
Time -0.136 .449  -0.202 .375  0.006 .980 
Elevated BF% 0.137 .461  0.043 .831  0.250 .447 
DS * Normal BF% * Time REF   REF   -- -- 
DS * Elevated BF% * Time -0.056 .573  -0.022 .843  -- -- 
TD * Normal BF% * Time 0.034 .722  -- --  REF  
TD * Elevated BF% * Time 0.044 .775  -- --  -0.025 .862 
Random Effects         
var (morning) 0.160 <.001*  0.077    .028*  0.252 <.001* 
var (afternoon) 0.276 <.001*  0.214 <.001*  0.352 <.001* 
var (night) 0.496 <.001*  0.611 <.001*  0.370 <.001* 
Intercept 0.143 <.001*  0.139    .001*  0.133   .009* 
 
Note: DS = Down syndrome; TD = typical development; BF% = body fat percentage; Sex = reference is female. 
--  not included in model  
*  p < .05, bolded 
† p < .10, italicized 
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Table 2.6.  Linear mixed model on diurnal cortisol, Down syndrome, and physical activity level (Model 3) 
 
Dependent Variable: Ln Cortisol (μg/dL) Model 3a  Model 3b  Model 3c 
 Total  Down syndrome  Typical Development 
Predictor b p  b p  b p 
Intercept -0.710 .001*  -0.715 .007*  -1.015 .001* 
Fixed effects         
Down syndrome (DS) REF   -- --  -- -- 
Typical development (TD) -0.226 .158  -- --  -- -- 
Sex 0.095 .358  0.011 .942  0.225 .116 
Hours -0.112 <.001*  -0.101 .001*  -0.123 .001* 
Time -0.220 .221  -0.244 .286  -0.046 .851 
MVPA (< 30 min/day) -0.167 .296  0.005 .981  -0.342 .158 
DS * Less MVPA * Time REF   REF   -- -- 
DS * More MVPA * Time 0.147 .112  0.077 .459  -- -- 
TD * Less MVPA * Time 0.110 .226  -- --  REF  
TD * More MVPA * Time 0.177 .113  -- --  0.109 .323 
Random Effects         
var (morning) 0.154 <.001*  0.081    .024*  0.226 <.001* 
var (afternoon) 0.273 <.001*  0.203 <.001*  0.365 <.001* 
var (night) 0.509 <.001*  0.620 <.001*  0.381 <.001* 
Intercept 0.143 <.001*  0.135   .001*  0.137   .008* 
 
Note: DS = Down syndrome; TD = typical development; MVPA = moderate to vigorous physical activity (minutes per day);  
Sex = reference is female. 
--  not included in model  
*  p < .05, bolded 
† p < .10, italicized 
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Table 2.7.  Linear mixed model on diurnal cortisol, Down syndrome, elevated fat mass, and physical activity level (Model 4) 
 
Dependent Variable: Ln Cortisol (μg/dL) Model 4a  Model 4b  Model 4c 
 Total  Down syndrome  Typical Development 
Predictor b p  b p  b p 
Intercept -0.756 .002*  -0.654 .014*  -1.040 .002* 
Fixed effects         
Down syndrome (DS) REF   --   --  
Typical development (TD) -0.183 .301  --   --  
Sex 0.187 .056†  0.178 .149  0.247 .097† 
Hours -0.094 <.001*  -0.599 .010*  -0.121 .001* 
Time -0.432 .022*  -0.066 .034*  -0.710 .779 
Elevated BF% 0.165 .367  0.120 .564  0.059 .869 
MVPA (< 30 min/day) -0.114 .472  0.098 .638  -0.322 .237 
DS * Normal BF% * Less MVPA * Time REF   REF   -- -- 
DS * Normal BF% * More MVPA * Time 0.588 <.001*  0.530 <.001*  -- -- 
DS * Elevated BF% * Less MVPA * Time 0.193 .091†  0.221 .076†  -- -- 
DS * Elevated BF% * More MVPA * Time 0.106 .411  0.047 .728  -- -- 
TD * Normal BF% * Less MVPA * Time 0.212 .050*  -- --  REF  
TD * Normal BF% * More MVPA * Time 0.265 .034*  -- --  0.125 .310 
TD * Elevated BF% * Less MVPA * Time 0.231 .142  -- --  0.048 .765 
TD * Elevated BF% * More MVPA * Time a a  -- --  a a 
Random Effects         
var (morning) 0.175 <.001*  0.117 .002*  0.232 .001* 
var (afternoon) 0.279 <.001*  0.203 <.001*  0.357 <.001* 
var (night) 0.456 <.001*  0.522 <.001*  0.390 <.001* 
Intercept 0.098 .001*  0.050 .079†  0.138 .008* 
 
Note: DS = Down syndrome; TD = typical development; BF% = body fat percentage; MVPA = moderate to vigorous physical activity 
(minutes per day); Sex = reference is female; -- Not included in model;  
a  Unable to calculate due to no observations (n = 0) 
*  p < .05, bolded  
† p < .10, italicized 
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Figure 2.1  Diurnal cortisol pattern in adolescents with and without Down syndrome 
 
 
 
Cortisol (μg/dL) across time points. Analyses are based on log-transformed cortisol.  Post-hoc linear independent pairwise corrections 
with Bonferroni corrections based on estimated marginal means controlling for sex and hours since waking.  (*) Differences in cortisol 
between adolescents with Down syndrome and typical development, p < .05 (no differences observed) 
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Figure 2.2  Association between diurnal cortisol pattern, adiposity, and physical activity in adolescents with typical development 
 
 
 
Cortisol (μg/dL) across time points. Analyses used log-transformed cortisol. Pairwise comparisons with Bonferroni corrections on 
estimated marginal means controlling for sex and hours since waking. TD = typical development, DS = Down syndrome, BF% = body 
fat percentage (elevated or normal), MVPA = moderate to vigorous physical activity (< 30 minutes or ≥ 30 minutes/day). 
* Differences in cortisol across MVPA (30 min/day) groups, among adolescents with elevated body fat percentage, p < .05. 
# Differences in cortisol across MVPA (30 min/day) groups, among adolescents with normal body fat percentage, p < .05. 
† Differences in cortisol across body fat percentage groups, among adolescents engaging in ≥ 30 minutes of MVPA per day, p < .05. 
‡ Differences in cortisol across body fat percentage groups, among adolescents engaging in < 30 minutes of MVPA per day, p < .05. 
Note: no differences observed. 
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Figure 2.3. Association between diurnal cortisol pattern, adiposity, and physical activity in adolescents with Down syndrome  
 
 
 
Cortisol (μg/dL) across time points. Analyses used log-transformed cortisol. Pairwise comparisons with Bonferroni corrections on 
estimated marginal means controlling for sex and hours since waking. DS = Down syndrome, BF% = body fat percentage (elevated or 
normal), MVPA = moderate to vigorous physical activity (< 30 minutes or ≥ 30 minutes/day). 
* Differences in cortisol across MVPA (30 min/day) groups, among adolescents with elevated body fat percentage, p < .05 (no 
differences observed; trending toward significance, p < .10: Afternoon = .091, Night = .064). 
# Differences in cortisol across MVPA (30 min/day) groups, among adolescents with normal body fat percentage, p < .05. 
† Differences in cortisol across body fat percentage groups, among adolescents engaging in ≥ 30 minutes of MVPA per day, p < .05. 
‡ Differences in cortisol across body fat percentage groups, among adolescents engaging in < 30 minutes of MVPA per day, p < .05. 
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CHAPTER 3 
Salivary cortisol response to acute exercise in adolescents with and without Down syndrome 
Introduction 
The public health crisis related to the high rates of childhood obesity is well documented 
(Ogden, Carroll, Kit & Flegal, 2014; Speiser et al., 2005; World Health Organization, 2012). 
However, less attention has been cast on the obesity-related health disparities among individuals 
with intellectual disabilities (Rimmer, Wang, Yamaki & Davis, 2009; Rimmer & Yamaki, 2006). 
Down syndrome, the most common genetic form of intellectual disability (Parker et al., 2010), is 
associated with increased risk for obesity. Prevalence rates of obesity among children and 
adolescents with Down syndrome exceed 30% (Rimmer, Yamaki, Lowry, Wang & Vogel, 
2010), which is nearly twice the obesity rate among the general population (16.9%; Ogden et al., 
2014). This health disparity represents a critical barrier to quality of life. A common 
recommendation to address the excess obesity in both general and disability populations is to 
increase levels of physical activity among youth (U.S. Department of Health and Human 
Services, 2002, 2005, 2008; World Health Organization, 2012). However, the physiological 
responses to exercise, particularly with regards to obesity, in youth with Down syndrome are not 
clearly understood and are in need of further examination. 
 Due to the phenotypic characteristics of Down syndrome, there exist multiple 
physiological differences that impact physical fitness and responses to acute exercise in this 
population (Baynard, Pitetti, Guerra, Unnithan & Fernhall, 2008; Mendonca, Pereira & Fernhall, 
2010b; Pitetti, Baynard & Agiovlasitis, 2013). Most notably, peak aerobic capacity  (VO2peak) 
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(Fernhall et al., 1996; Mendonca, Pereira & Fernhall, 2010a; Mendonca, Pereira, et al., 2010b; 
Mendonca, Pereira, Morato & Fernhall, 2010) and peak heart rate (Baynard, Pitetti, Guerra & 
Fernhall, 2004; Fernhall et al., 2001; Fernhall et al., 1996; Figueroa et al., 2005; Guerra, Llorens 
& Fernhall, 2003; Mendonca, Pereira, et al., 2010a; Mendonca, Pereira, Morato, et al., 2010) are 
significantly lower among youth and adults with Down syndrome compared to both peers with 
typical development or non-genetic forms of intellectual disabilities. A recent study (Wee et al., 
2015) found that aerobic capacity, but not peak heart rate, was associated with obesity in adults 
with Down syndrome. However, significant associations were not observed among youth with 
Down syndrome for either variable, suggesting that the relationship between aerobic capacity 
and obesity may be age-dependent in this population. Baynard et al. (2008) found significant 
differences in absolute and relative VO2 between individuals with and without Down syndrome 
across ages, with the largest differences observed among children. The majority of studies on 
aerobic capacity have been conducted in adults with Down syndrome, leaving children and 
adolescents with Down syndrome as underrepresented sub-populations in the research literature. 
Given the effect of age on lower aerobic capacity and the high rates of pediatric obesity in Down 
syndrome, this relationship needs to be further examined. 
 While obesity may have a small effect on aerobic capacity (Wee et al., 2015), the primary 
causes of low aerobic capacity in Down syndrome are blunted catecholamine responses, altered 
autonomic responses, and chronotropic incompetence (Fernhall et al., 2009; Fernhall, Mendonca 
& Baynard, 2013; Mendonca, Pereira, et al., 2010b). Catecholamines (e.g. epinephrine, 
norepinephrine) in adults with Down syndrome appear to be less responsive to maximal and 
submaximal exercise compared to typically developing controls (Bricout et al., 2008; Fernhall et 
al., 2009). The lack of exercise response is critical as catecholamines drive heart rate response 
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above the anaerobic threshold (Fernhall et al., 2009). In addition to measuring catecholamines, 
Bricout et al. (2008) attempted to further explain reduced aerobic capacity in young adults with 
Down syndrome through a variety of hormonal responses to exercise. A novel finding from this 
study was that cortisol levels also differed in young adults with Down syndrome, including lower 
resting cortisol levels and a blunted response to submaximal exercise (Bricout et al., 2008). This 
may be an indication of dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis.  
The HPA axis is responsible for regulating energy storage and energy expenditure (Adam 
& Epel, 2007; Bjorntorp, 2001). Cortisol, a glucocorticoid, is released from the adrenal gland 
(Adam & Epel, 2007; Bjorntorp, 1996, 2001; Bjorntorp & Rosmond, 2000; De Vriendt, Moreno 
& De Henauw, 2009) and responds directly to stressors. Cortisol is strongly associated with 
adiposity in the abdominal region, likely due to increased levels of glucocorticoid receptors in 
this type of tissue (Bjorntorp & Rosmond, 2000; De Vriendt et al., 2009; Rodriguez et al., 2015). 
Cortisol dysregulation in children and adolescents is associated with greater body mass index 
(BMI) or BMI z-score (Hill, Eisenmann, Gentile, Holmes & Walsh, 2011; Misra et al., 2008; 
Ondrak, McMurray, Hackney & Harrell, 2011; Reinehr et al., 2014; Rosmalen et al., 2005; 
Ruttle et al., 2013), waist circumference (Guzzetti, Pilia, Ibba & Loche, 2014; Hill et al., 2011; 
Reinehr et al., 2014), and abdominal fat mass (Barat et al., 2007; Misra et al., 2008; 
Weigensberg, Toledo-Corral & Goran, 2008). Similar relationships have consistently been 
shown in adults (Adam & Epel, 2007; Anagnostis, Athyros, Tziomalos, Karagiannis & 
Mikhailidis, 2009; Bjorntorp, 1996, 2001; De Vriendt et al., 2009; Foss & Dyrstad, 2011). The 
majority of this research shows that higher cortisol levels are associated with greater adiposity, 
however, other studies have shown the opposite direction of association (Ondrak et al., 2011; 
Ruttle et al., 2013). 
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Physical exercise, considered a positive stressor, can activate HPA axis activity, 
including cortisol release. During and after exercise, cortisol helps mediate physiological 
mechanisms that maximize exercise capacity and recovery. In adults, exercise of sufficient 
intensity and/or duration can significantly increase cortisol levels (Hackney, 2006; Hill et al., 
2008; Jacks, Sowash, Anning, McGloughlin & Andres, 2002; Rudolph & McAuley, 1998; Viru 
& Viru, 2004). However, cortisol responses to exercise in youth are highly variable (Rubin, 
Tufano & McMurray, 2013). Multiple studies have shown significant increases in cortisol in 
children (Aucouturier et al., 2013; del Corral, Mahon, Duncan, Howe & Craig, 1994) and 
adolescents (Hackney et al., 2011; Viru, Laaneots, Karelson, Smirnova & Viru, 1998) in 
response to exercise; while others found no significant changes (Eliakim et al., 2006; Galassetti 
et al., 2006). Pubertal stage may be an important factor to explain the variability in cortisol 
response  (Hackney et al., 2011; Viru et al., 1998). The cortisol response to exercise may also be 
affected by obesity in children. A recent study compared cortisol levels at rest and in response to 
exercise between lean and obese children (Aucouturier et al., 2013). Resting cortisol levels were 
similar between lean and obese children, but the cortisol response to exercise was significantly 
lower in obese children. Conversely, Eliakim et al. (2006) did not find a significant cortisol 
response to exercise in either lean or obese youth. Despite non-significance, the direction of 
change favored a cortisol increase among lean youth and a blunted cortisol response among 
obese youth.  
As noted previously, evidence on cortisol function in Down syndrome is very limited. 
Previous studies in persons with Down syndrome have examined cortisol in single measure 
(Anneren, Sara, Hall & Tuvemo, 1986; Arnell, Gustafsson, Ivarsson & Anneren, 1996; Hestnes 
et al., 1991; Murdoch, Giles, Grant & Ratcliffe, 1979), during stress tests (Murdoch et al., 1979), 
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and during periods of rest and exercise (Bricout et al., 2008). Most studies have found cortisol 
levels to be within normal limits, but these are also limited by measuring at only a single time 
point (Anneren et al., 1986; Arnell et al., 1996; Hestnes et al., 1991; Murdoch et al., 1979). 
Bricout et al. (2008) reported that young adult males with Down syndrome exhibited lower 
cortisol levels at rest and significantly lower responses to physical exercise across multiple time 
points. Similarly stunted cortisol responses have been reported during stress tests in adults with 
Down syndrome (Murdoch et al., 1979). While Bricout et al. (2008) had differences in fat mass 
between subjects with and without Down syndrome, results comparing cortisol and adiposity 
were not examined. 
Due to the association between cortisol function and fat mass, an examination of this 
hormone in adolescents with Down syndrome was warranted. It is currently unclear if the 
cortisol responses to exercise observed in adults Down syndrome are similar in adolescents or if 
this hormonal response is associated with adiposity within a population at risk for obesity. 
Adolescence is a developmental period of particular interest due to changes in adrenal function 
during puberty (Hackney et al., 2011; Viru et al., 1998), and unique growth trajectories in Down 
syndrome (Cronk et al., 1988; Van Gameren-Oosterom et al., 2012); both of these factors may 
influence the development of obesity. Exercise should promote energy substrate metabolism, but 
blunted cortisol responses coupled with the established limits in aerobic capacity may limit the 
potential for metabolic health benefits from physical activity among adolescents with Down 
syndrome.  
The purpose of this study was to examine differences in cortisol concentration during 
periods of rest, a bout of moderate-intensity exercise, and recovery from exercise between 
adolescents with and without Down syndrome. Furthermore, the study sought to examine the 
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association between cortisol patterns and adiposity. Cortisol response in this study was examined 
within the context of the established limitations in aerobic capacity and heart rate response 
among individuals with Down syndrome. 
Methods 
Participants 
All methods and procedures for the study were approved by the Institutional Review 
Board of the University of Michigan Medical School. All parents signed written informed 
consent documents while participants completed written or verbal assessment prior to initiating 
the study. Adult participants (e.g. 18 years old) were allowed to independently provide written 
informed consent, however parents of adult participants with Down syndrome also provided 
written consent. Participants were recruited through Down syndrome parent support groups in 
Michigan and northern Ohio. Typically developing adolescents were recruited through family 
referrals, local school districts, and from previous study samples. Inclusion criteria for 
participation included ages 12 to 18 years old and pubertal Tanner stages III-V (Marshall & 
Tanner, 1969, 1970). Exclusion criteria included: a) dual disability diagnosis (e.g. autism); b) 
comorbid disease (e.g. diabetes); c) contraindication limiting ability to safely perform physical 
exercise (e.g. cardiac insufficiency); d) use of medication that could alter metabolic functions 
(e.g. prednisone, central nervous systems stimulants, growth hormone, thyroid hormone); e) 
documented history of hormonal insufficiency (e.g. hypothyroid); and f) severe behaviors that 
would prevent safe performance of the exercise protocol. Distributions of sex, age, and Tanner 
pubertal stage were similar based on comparison of group means. 
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Clinical Visit  
Data collection was completed during a single day for all participants. Dual-energy X-ray 
absorptiometry (DXA) scans were completed at the Michigan Clinical Research Unit within the 
University of Michigan Hospital. All other procedures including the exercise protocol were 
conducted in the Childhood Disparities Research Lab within the University of Michigan School 
of Public Health. All exercise trials took place in the morning (M = 10:52 AM, SD = 1 hour, 10 
minutes). Most participants (65%) completed the DXA scan before starting the exercise trial (M 
= 10:17 AM, SD = 2 hours, 43 minutes). [Note: No differences were observed in cortisol levels 
at any point during the protocol between participants that completed the DXA scan before or 
after the exercise trial, p > .20] 
Questionnaires 
Parents completed a series of questionnaires. The accompanying parent was used as a 
proxy-reporter to ensure consistency between participants with and without Down syndrome.  
Sociodemographic Survey. A basic survey was used to document the participant’s age, 
race/ethnicity, current medication use, comorbidities, and relevant behaviors. 
Pubertal Staging: Tanner pubertal staging was measured via parental report using line 
drawings (Morris & Udry, 1980). Parental reports can provide an acceptable and reliable report 
of pubertal stage (Brooks-Gunn, Warren, Rosso & Gargiulo, 1987; Coleman & Coleman, 2002; 
Dorn, Susman, Nottelmann, Inoffgermain & Chrousos, 1990; Petersen, Crockett & Richards, 
1988; Shirtcliff, Dahl & Pollak, 2009), and are less invasive and stressful than a physical 
assessment of Tanner stage (Marshall & Tanner, 1969, 1970). Stress directly influences cortisol 
levels (Bjorntorp, 2001; Chrousos & Gold, 1992; De Vriendt et al., 2009; Tsigos & Chrousos, 
2002), which could skew study outcomes. Participants were limited to adolescents in Tanner 
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stages III to V, operationalized as the average of two reported stages for each participant (i.e. 
breast and pubic hair development in females or genital and pubic hair development in males). 
Anthropometry 
All anthropometric measurements were conducted according to guidelines from Lohman 
(Lohman, Roche & Martorell, 1988). Height and weight were measured to the nearest 0.1 
centimeter (SECA S-214 stadiometer) and nearest 0.01 kilogram (Health O Meter H-349KL 
digital scale), respectively. Each measurement was taken in duplicate; if measures differed by 
greater than 0.5 cm or 0.5 kg, respectively, a third trial was taken. Data reported are the average 
of all trials. BMI (kg/m2) and BMI percentile from the CDC growth reference (Kuczmarski et al., 
2000) were then calculated to classify body composition into overweight and obese categories. 
Dual-Energy X-Ray Absorptiometry 
 Each participant completed one DXA scan (GE Lunar Prodigy Advance [DPX-IQ 240] 
densitometer; Lunar Radiation Corp., Madison, WI) at the MCRU. DXA scans with the Lunar 
Prodigy are highly correlated with advanced imaging technologies (e.g. computed tomography 
and magnetic resonance imaging), reliable in pediatric populations, and recommended for use in 
epidemiological obesity research (Kendler et al., 2013; Margulies et al., 2005). DXA scans 
involve a low radiation dose (0.37 μSv), equivalent to the radiation absorbed during a typical day 
(Albanese, Diessel & Genant, 2003); this radiation dose is considered medically negligible.  
All participants in the current study completed a valid scan. The Lunar Prodigy was 
calibrated daily according to manufacturer instructions using a standardized block. Participants 
wore light clothing and were positioned in a supine position with hands by the sides in a neutral 
position. Pediatric DXA software (EnCore v.14.10) calculated body fat mass and total body fat 
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percentage. Obesity was classified based on age- and sex-specific cut-points for elevated body 
fat percentage (Freedman et al., 2009). 
Exercise Protocol 
Figure 1 depicts the protocol each participant completed. Participants began by sitting 
(T0) for a period of 20 minutes to allow heart rate, metabolic rate, breathing rate, and cortisol to 
reach resting levels (T1). Following the rest period, each participant completed a graded 
submaximal bout of exercise culminating at 70% predicted maximal HR (HRmax) by walking on 
a motorized treadmill. The protocol was modified from VO2peak testing protocols designed for 
adults with Down syndrome (Fernhall et al., 2001; Fernhall, Millar, Tymeson & Burkett, 1990; 
Mendonca, Pereira & Fernhall, 2009, 2011) and children with intellectual disabilities (Vashdi, 
Hutzler & Roth, 2008). The exercise bout consisted of two 10 minute phases, totaling 20 minutes 
of exercise. Phase 1 included incremental graded walking to gradually increase heart rate. 
Participants began at an easy walking speed (1.5 mph, 0% grade) for acclimation. After 2 
minutes, the treadmill speed was increased to 2.5 mph. The incline of the treadmill was then 
increased by 2.5% every 2 minutes until the target heart rate ranged was reached. If necessary, 
speed was incrementally increased (0.6 mph/increase) once the treadmill was at 9% grade, until 
reaching the target heart rate. Phase 2 was intended to be 10 minutes of continuous steady-state 
exercise within the target heart rate range (70 ± 5%) of predicted HRmax. Equations specific to 
persons with intellectual disabilities (Fernhall et al., 2001) were used for adolescents with Down 
syndrome (Equation 3.1) while traditional age-predicted HRmax equations were used for 
typically developing adolescents (Equation 3.2). Following the exercise segment (T2), the 
participant was monitored during seated resting recovery for a total of 40 minutes in two 20-
minute periods (T3 and T4).  
113 
Participants were familiarized and oriented to treadmill exercise prior to data collection. 
Familiarization procedures allowed each participant to practice walking on the treadmill and 
breathing with the facemask. This practice occurred on the same day as the data collection; 
usually prior to the DXA scan appointment. Numerous researchers using treadmill protocols in 
persons with intellectual disabilities have cited familiarization as an important aspect of the 
measurement protocol (Balic, Mateos, Blasco & Fernhall, 2000; Fernhall & Tymeson, 1987; 
Pitetti, Rimmer & Fernhall, 1993; Vashdi et al., 2008). Participants were encouraged throughout 
the exercise and provided positive reinforcement to increase compliance (Vashdi et al., 2008). 
Exercise Measurement 
Saliva Sampling. Saliva sampling was conducted with an oral swab (Salimetrics, State 
College, PA). Participants placed the swab underneath the tongue to absorb saliva. Each sample 
took approximately 3 minutes to complete and produced approximately 1 mL of saliva for 
analysis. Samples will be taken at four time points (T1, T2, T3, T4) during the protocol. Each 
saliva sample was stored in an individually numbered polypropylene vial and frozen (-20 °C) 
before extraction and analysis. Samples were analyzed in duplicate for levels of cortisol 
concentration (µg/dL), using enzyme-linked immunosorbent assay (ELISA) techniques with the 
Expanded High Range Sensitivity Salivary Cortisol Enzyme Immunoassay Kit (Salimetrics, 
State College, PA). The assay has a lower limit of sensitivity (minimum detectable 
concentration) of 0.007 µg/dL (Shirtcliff, Granger, Schwartz & Curran, 2001). Inter-assay and 
intra-assay coefficients of variation (%CV) were 5.62% and 5.27%, consistent with 
recommendations (Reed, Lynn & Meade, 2002).  
Cortisol concentration from saliva samples was operationalized using two techniques. 
First, group means and standard deviations were calculated across each cortisol measurement 
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(T0, T2, T3, T4) for analyses of group differences. Second, trapezoidal area under the curve 
(AUC) controlling for time between measurements was used to capture cortisol output during the 
protocol. AUC equations were modified from Pruessner et al. (2003) to match the parameters of 
the present study (Equations 3.3 and 3.4). AUCg represents the total cortisol output during a 
given period. AUCΔ represents the change in cortisol output during a given period, accounting 
for initial cortisol concentration. AUC was calculated for the full protocol (T1:T4), the exercise 
response (T1:T2), and the recovery response (T2:T4). 
  Indirect calorimetry. Gas exchange was measured breath-by-breath continuously 
throughout the laboratory protocol (T0:T4), except when completing saliva samples, using the 
Oxycon mobile ergospirometry system (Yorba Linda, CA). Participants wore a flexible silicone 
facemask (covering the mouth and nose) and the lightweight Oxycon system attached to their 
back with a harness. Before each test, the Oxycon was calibrated for flow control and gas 
calibration (4% CO2 and 16% O2) using automated calibration functions according the 
manufacturer’s instructions. The Oxycon system has been shown to provide valid and reliable 
measures of respiratory gas exchange in comparison to traditional methodology and across a 
variety of settings and exercise intensities (Hannink et al., 2010; Rosdahl, Gullstrand, Salier-
Eriksson, Johansson & Schantz, 2010; Salier-Eriksson, Rosdahl & Schantz, 2012). Respiratory 
gas exchange values from final five minutes of each segment were used for analyses (T1, T2, T3, 
T4). Physiological parameters included absolute gas exchange (oxygen consumption, VO2; 
carbon dioxide production, VCO2; mL∙min-1), relative gas exchange (VO2, VCO2; mL∙kg-1∙min-
1), respiratory exchange ratio (RER; VCO2/VO2), and minute ventilation (VE; L∙min-1), 
calculated in 1-minute averages. Heart rate was measured continuously throughout the laboratory 
protocol (T0:T4) using a Polar Vantage (Polar Electro, Woodbury, NY) heart rate monitor. Heart 
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rate (bpm) was calculated in 1-minute averages and presented as the percentage of predicted 
HRmax. Predicted VO2 was also calculated (Equations 3.5 and 3.6) based on the speed, grade 
and exercise mode (walking or running) during the final five minutes of the exercise bout 
(American College of Sports Medicine, 2013) and compared with measured VO2 during the 
same phase to calculate cardiorespiratory efficiency (Equation 3.7). Work rate (watts) was also 
calculated based on the participant weight, treadmill speed, and treadmill slope (Equation 3.8). 
Statistical Analyses  
Data analyses were performed using SPSS 22.0 (IBM Corp., Armonk, NY) with an a 
priori α of 0.05. Demographics of the sample were described using descriptive statistics, 
independent t-tests, and Pearson’s Chi-square (X 2) tests. 
A two-way (group (2) x time (4)) repeated measures analysis of covariance 
(RMANCOVA) was employed to examine differences in cortisol and other physiological 
measures between groups with Down syndrome and typical development across the four time 
points of the protocol. Planned comparisons were conducted with Bonferroni corrections. 
Comparisons examined group differences at each time point, differences between each time 
point and baseline, and between each time point and the preceding time point. Cohen’s d effect 
size was also calculated for unadjusted group differences. A follow-up two-way (group (4) x 
time (4)) RMANCOVA were then conducted to examine an interaction between disability 
groups and elevated body fatness. All analyses controlled for age, sex, and Tanner pubertal stage. 
Results are reported as estimated marginal means and standard errors. 
Results 
 A total of 26 participants (12 with Down syndrome, 14 with typical development) 
completed the exercise protocol. All participants (100%) who began the session were able to 
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successfully complete the 80 minute protocol including 20 minutes of sustained exercise. 
Descriptive statistics and demographic information for the participants are presented in Table 
3.1. No differences were observed between groups on age, sex, or Tanner stage (p > .70). 
Adolescents with Down syndrome were significantly shorter in stature than adolescents with 
typical development (p < .001); but were similar in weight (p = .682). All indices of body 
composition show that the adolescents with Down syndrome were significantly more overweight 
than typically developing peers (p < .05). DXA scan data identified an elevated body fat 
percentage in 67% (n = 8) of adolescents with Down syndrome and 21% (n = 3) of adolescents 
with typical development. 
 The exercise protocol was designed to reach and maintain 70% (± 5%) of predicted 
HRmax during the second 10 minutes of the bout. Due to the differences in heart rate response to 
exercise between groups, absolute exercise levels were higher among adolescents with typical 
development. Figure 3.2 shows the differences in work rate during the exercise bout. Both 
groups reached the desired HRmax range during the exercise. Adolescents with Down syndrome 
averaged 76.3% of predicted HRmax while typically developing adolescents averaged 73.9% of 
predicted HRmax during the final five minutes of exercise. The typically developing group 
exercised at a faster walking speed (3.81 mph) and with greater incline (8.54% grade) than the 
group with Down syndrome (2.26 mph, 3.97% grade; p < .001). This resulted in significant 
differences in work rate (watts, W) during the exercise trial. The ability to describe work rate, 
however, is limited in the group with Down syndrome as four participants completed the 
exercise phase without any incline. This resulted in an estimated work rate of 0 W. To account 
for this issue, results are presented with the full estimated work rate (n = 12) and with 0 W 
treated as missing data (n = 8). Adolescents with typical development exercised at a significantly 
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higher work-rate (83.3 W) than adolescents with Down syndrome (22.5 W and 33.8 W) 
regardless of descriptive statistics approach (p < .001). Despite matching groups on relative 
exercise intensity (% of predicted HRmax), there were large differences in the absolute workload 
that could affect cardiometabolic and physiological responses to the exercise bout. 
 Cardiopulmonary data across the four stages of the protocol are shown in Table 3.2. 
Systematic errors in the measurement of VCO2 resulted in unusable data; thus neither VCO2 nor 
RER (a function of the relationship between VO2 and VCO2) could be interpreted (data not 
shown). A significant multivariate effect of disability group by time was observed, F(24, 145.62) 
= 17.53, p < .001, Wilk’s λ = 0.02. Significant univariate effects of the two-way disability by 
time interaction included relative heart rate (p = .05), absolute heart rate (p < .001), absolute VO2 
(p < .001), relative VO2 (p < .001), and ventilatory exchange (p = .01). The analysis was 
repeated to examine the three-way interaction of disability and body fatness groupings across 
time (Table 3.3). A significant multivariate effect of disability group by fatness by time was also 
observed, F(24, 145.62) = 2.39, p < .001, Wilk’s λ = 0.38, but only relative VO2 (p = .01) and 
ventilatory exchange (p = .03) had a significant univariate effects. All analyses account for 
sphericity through Greenhouse-Geisser corrections (ε < 0.66).  
 To better understand the differences in cardiopulmonary variables, most notably VO2, 
cardiorespiratory efficiency during the exercise phase was examined. Figure 3.3 shows the 
differences in estimated relative VO2 (given the speed, incline, and exercise mode during the 
final five minutes of exercise), actual relative VO2 (during the final five minutes of the exercise), 
and efficiency (estimated/actual VO2). Calculated efficiency was significantly lower among 
adolescents with Down syndrome (71.8%) compared to typically developing adolescents 
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(108.6%). This suggests that adolescents with Down syndrome had measured energy expenditure 
values that were almost 30% greater than expected for a given work rate.  
Figures 3.4 through 3.8 show the cardiopulmonary data across the protocol to examine 
differences between adolescents with and without Down syndrome (left side of figures) and 
differences across disability and elevated fatness groupings (right side of figures). Significant 
group differences between adolescents with Down syndrome and typical development were 
observed across all time points for relative heart rate (p < .03) and during the exercise bout for 
absolute heart rate (p <.001), absolute VO2 (p <.001), relative VO2 (p = .001), and ventilatory 
exchange (p = .001). No differences were observed at any time points in adolescents with Down 
syndrome between elevated and normal body fatness (p > .05). However, differences by body fat 
groupings in typically developing adolescents were significant during exercise for relative VO2 
(p = .002) and ventilatory exchange (p = .03). Lastly, significant differences between adolescents 
with and without Down syndrome within a body fatness group were also observed during 
exercise for absolute heart rate (p <.001), absolute VO2 (p <.001), relative VO2 (p = .001), and 
ventilatory exchange (p <.01) and across all three resting phases (T1, T3, T4) for relative heart 
rate (p < .03).  
As expected, a significantly lower heart rate response (p < .001) and aerobic response (p 
< .001) were observed during exercise for adolescents with Down syndrome compared to 
typically developing adolescents. However, a novel finding is that relative VO2 (controlling for 
body mass) was not different between typically developing adolescents with elevated body fat 
and adolescents with Down syndrome (p > .60). 
 Finally, cortisol concentration across the protocol is presented in Table 3.4 and Figure 
3.9. There were no significant univariate effects on cortisol for two-way disability by time 
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interaction, F(1.77) = 0.77, p = .455, nor the three-way interaction of disability and body fatness 
groupings across time,  F(1.82) = 1.63, p = .213. No significant differences were observed in 
planned comparisons between any possible groupings nor between time points (p < .05). Due to 
small sample size, Cohen’s d examined group differences independent of sample size. Large 
effect sizes were observed at baseline for cortisol differences by body fatness within typically 
developing adolescents (d = 1.03) and within adolescents with Down syndrome (d = 1.09), as 
well as differences between Down syndrome and typical development among adolescents with 
elevated body fatness (d = 0.88). During exercise, large effect sizes were once again observed 
between body fatness groupings within typical development (d = 0.87) and Down syndrome (d = 
1.01). During the first recovery phase, a large effect size was only observed between body 
fatness groupings among adolescents with Down syndrome (d = 0.82). No substantial effect sizes 
were observed during the second recovery phase. These effect sizes that suggest that while 
significant differences cannot be determined due to lack of statistical power, there may still be 
meaningful differences in cortisol concentration between groups.  
 Area under the curve was also examined for total cortisol output and change in output 
across time points (Table 3.5). Significant differences in the AUCΔ during the recovery phase 
(T2:T4) were observed between disability groups (p = .048) and between body fatness groupings 
within typically developing adolescents (p = .049). AUCg during the exercise phase (T1:T2) also 
trended toward significant between body fat groupings within typically developing adolescents 
(p = .085). Despite the limited number of significant differences, multiple large effect sizes were 
observed in both AUCΔ and AUCg. 
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Discussion 
This study sought to elicit a cortisol response through a bout of moderate-intensity 
exercise and compare differences in this response between adolescents with and without Down 
syndrome and with and without elevated fatness. No changes in salivary cortisol were observed 
across any of the phases of the protocol. However, there were multiple differences in cortisol 
concentration between adolescents with high and normal body fatness as observed through large 
effect sizes. As expected, there were also pervasive differences in the heart rate and aerobic 
responses in adolescents with Down syndrome compared to peers with typical development 
during the same relative exercise intensity.  
Cortisol levels were unresponsive to the protocol in both groups. The measurement of 
salivary cortisol instead of blood (plasma or serum) or urine cortisol may be partially responsible 
for this lack of response. While cortisol levels in saliva can respond quickly to a stimulus (e.g. 
exercise, stress), there may also be a delay in peak cortisol response. Thus, it is possible that the 
anticipated responses occurred in between the four measurement time points. However, the 
consistently flat nature of cortisol concentration over the protocol and low levels of variance 
between measurements would suggest this is unlikely. While a blunted cortisol response in the 
Down syndrome group is consistent with previous studies (Bricout et al., 2008), the lack of 
response among typically developing adolescents make any group comparisons difficult to 
interpret. 
Bricout et al. (2008) found significantly lower cortisol levels across a 2.5-hour period of 
rest and a blunted response to exercise in young adult males with Down syndrome compared to 
controls. No differences were observed between time points of either the rest or exercise 
protocols among these young adults with Down syndrome, while significant changes occurred in 
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the control group. At each time point presented, young adults with Down syndrome exhibited 
lower cortisol levels than controls. The current study is consistent with these findings as no 
changes in cortisol were observed in adolescents with Down syndrome between rest, exercise, 
and extended recovery. We also found that adolescents with Down syndrome exhibited lower 
levels of cortisol across the protocol; however this difference was neither statistically significant 
nor of a large effect size. The levels of salivary cortisol observed in the current study of 
adolescents with Down syndrome reflect very similar blood cortisol levels to those previously 
reported in young adults with Down syndrome (Bricout et al., 2008). This would further support 
the initial hypothesis that cortisol response to exercise would be blunted in adolescents with 
Down syndrome.  
However, as noted previously, the control group did not respond as expected which limits 
the inferences that can be made from the study results. Exercise in adults consistently induces an 
increase in cortisol, provided the exercise bout is performed at a sufficient intensity and duration 
(Hackney, 2006; Hill et al., 2008; Jacks et al., 2002; Rudolph & McAuley, 1998; Viru & Viru, 
2004). The increase in cortisol observed among the Bricout et al. (2008) control group during 40 
minutes of progressive exercise culminating at 75% of VO2max was representative of the 
expected response. Cortisol reactivity in adolescents is highly variable as both significant 
increases in cortisol (Hackney et al., 2011; Viru et al., 1998) and no changes (Eliakim et al., 
2006; Galassetti et al., 2006) have been reported in response to exercise. Pubertal stage may be 
an important factor to explain the variability in cortisol response  (Hackney et al., 2011; Viru et 
al., 1998). Thus, the lack of response may be due to having more typically developing 
adolescents at Tanner stage III than were included in studies that found significant changes. It is 
also possible that progressive exercise for only 20 minutes culminating at 70% of predicted 
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HRmax in the current study was not of sufficient intensity or duration to elicit the expected 
response. 
A novel finding of this study was that differences began to emerge when groups were 
further divided into normal and elevated fatness groupings based on percent body fat (Freedman 
et al., 2009). The difference in total cortisol output across the protocol among adolescents with 
Down syndrome was substantially higher with elevated fatness compared to normal fatness. 
These differences were observed through large effect sizes, but did not reach statistical 
significance. The magnitude of differences in total cortisol output across the protocol was not as 
large between typically developing adolescents with and without elevated fatness; however, the 
difference in incremental cortisol output during recovery was significantly different in those with 
elevated body fat levels (p = .049). Typically developing adolescents with elevated fatness also 
had higher cortisol output during the exercise phase that trended toward statistical significance (p 
= .085). The cortisol patterns represented in Figure 3.9 also show that within each disability 
group, adolescents with elevated fat mass had higher levels of cortisol production throughout the 
protocol.  
These findings are consistent with much of the research literature that has found positive 
associations between cortisol levels and adiposity (Barat et al., 2007; Guzzetti et al., 2014; Hill et 
al., 2011; Misra et al., 2008; Reinehr et al., 2014; Rosmalen et al., 2005; Weigensberg et al., 
2008). Within exercise studies, Eliakim et al. (2006) did not find a difference in cortisol level 
between normal and obese children and adolescents during pre-exercise, peak exercise, or 120-
minute post-exercise measurements. Aucouturier et al. (2013) found a significantly blunted 
cortisol response to exercise in obese pre-pubescent children compared to lean controls, but 
cortisol levels outside of the exercise bout were similar. Given that no exercise response was 
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observed in the current study, it is difficult to infer whether differences in overall cortisol 
between groupings of fatness are related to exercise in any way. 
 Despite the lack of a true cortisol response to exercise, the protocol was effective in 
producing the desired cardiovascular exercise response. Lower heart rate response and aerobic 
capacity to exercise in Down syndrome have been well described in the literature (Fernhall et al., 
2013; Fernhall & Pitetti, 2001; Mendonca, Pereira, et al., 2010b). To account for these 
differences, a relative exercise intensity (70% predicted HRmax ± 5%) was used to standardize 
the protocol between groups. Each group averaged approximately 75% of their respective HRmax 
during the final five minutes of the exercise bout as intended. During exercise at the same 
relative intensity, adolescents with Down syndrome had significantly lower absolute heart rates 
and significantly lower absolute and relative (normalized to body mass) VO2. Efficiency during 
the final phase of exercise was also significantly lower among adolescents with Down syndrome.  
The heart rate and aerobic responses observed are consistent with the exercise physiology 
literature on adults with Down syndrome (Baynard et al., 2008; Fernhall et al., 2001; Guerra et 
al., 2003; Mendonca, Pereira, et al., 2010a; Wee et al., 2015). Previous studies have also 
consistently shown an increased energetic cost and lower economy during exercise in adults with 
Down syndrome (Agiovlasitis, McCubbin, Yun, Pavol & Widrick, 2009; Agiovlasitis, Motl, et 
al., 2011a, 2011b; Mendonca, Pereira, Morato, et al., 2010). These differences have clinical 
relevance as they directly impact physical fitness and likely contribute to decreased motivation to 
participate in physical activity. Furthermore, the altered metabolic rate has implications for the 
validity of a variety of physical activity measurement tools used in persons with Down 
syndrome, including pedometers (Agiovlasitis, Beets, Motl & Fernhall, 2012), accelerometers 
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(Agiovlasitis, Motl, Fahs, et al., 2011; Agiovlasitis, Motl, Foley & Fernhall, 2012), and heart rate 
index (Agiovlasitis et al., 2014). 
 The present study has a number of limitations that warrant serious consideration when 
interpreting these findings. First, the current sample is small in size, thus limiting statistical 
power in analyses. Many comparisons did not have statistically significant differences, yet very 
large effect sizes were observed. Repeating this study with a sample size consistent with 
statistical power is warranted, but would require substantial effort. For example, a power analysis 
on the difference in cortisol response during exercise between adolescents with Down syndrome 
with and without elevated fatness (d = 1.07) would have adequate statistical power (1-β = 80%, α 
= 5%) with 21 participants; 9 more participants with Down syndrome than are currently in the 
study. Second, recruiting for this study was very difficult due to timing required for the DXA 
scan and the inclusion of the treadmill exercise. Thus, the convenience sample of participants 
may not represent adolescents with Down syndrome. Third, the procedures and study design may 
have limited the ability to detect a cortisol response for exercise. While many studies use saliva 
sampling for cortisol measurement, most of the exercise-based studies discussed used blood 
samples. It is also possible that the employed exercise bout was not intense or long enough to 
produce the desired cortisol response. However, the heart rate and metabolic data do reflect that 
both participants with and without Down syndrome engaged in moderate-intensity exercise. 
Fourth, the measurement error regarding VCO2 is concerning. While the intention was always to 
focus on aerobic output through VO2 measurement, the lack of valid VCO2 meant that a valid 
RER could not be calculated. RER would have provided another index of exercise intensity as 
well as allowed for inferences regarding substrate utilization during the exercise bout. Although 
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the VO2 data appear to be appropriate both at rest and during exercise, these measurements from 
the Oxycon device must also be questioned in light of the errors in VCO2 measurement.  
Despite these limitations, this is the first study to attempt to elicit a cortisol response in 
adolescents with Down syndrome through exercise. The study is strengthened by the use of DXA 
to measure adiposity and classify groups. The finding of differences, as observed through effect 
size, based on having elevated or normal fatness is novel. Differences in the hormonal and 
aerobic responses to exercise could be related to the development of fat mass and high 
prevalence of obesity in this population. It is our hope that these findings, while limited, may 
encourage future investigations into the effect of cortisol on obesity in Down syndrome. 
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Equations 
Equation 3.1. HRmaxDS: predicted maximal heart rate for DS (Fernhall et al., 2001) 
  HRmaxDS = 210 – 0.56(age) – 15.5(DS) 
Equation 3.2. HRmaxTD: traditional predicted maximal heart rate 
  HRmaxDS = 220 – (age) 
Equation 3.3. AUCg: Area under the curve with respect to ground (total cortisol output) 
𝑨𝑨𝑨𝑨𝑨𝑨𝒈𝒈 =���𝒎𝒎(𝒊𝒊+𝟏𝟏) +𝒎𝒎𝒊𝒊�𝒕𝒕𝒊𝒊𝟐𝟐 �𝒏𝒏−𝟏𝟏
𝒊𝒊=𝟏𝟏
 
Equation 3.4. AUCΔ: Area under the curve with respect to increase (change within phase) 
𝑨𝑨𝑨𝑨𝑨𝑨𝜟𝜟 =���𝒎𝒎(𝒊𝒊+𝟏𝟏) +𝒎𝒎𝒊𝒊�𝟐𝟐 �𝒏𝒏−𝟏𝟏
𝒊𝒊=𝟏𝟏
−𝒎𝒎𝟏𝟏(𝐧𝐧 − 𝟏𝟏) 
Notation: time (t), measurements (m), total number of measurements (n) 
Both AUC equations are adapted from Pruessner et al. (2003) 
Equation 3.5. Estimated VO2 for walking (mL•kg-1•min-1) 
  VO2 = [0.1 x speed (m•min-1)] + [1.8 x speed (m•min-1) x grade] + 3.5 
Equation 3.6. Estimated VO2 for running (mL•kg-1•min-1) 
  VO2 = [0.2 x speed (m•min-1)] + [0.9 x speed (m•min-1) x grade] + 3.5 
    Both estimated VO2 equations are from ACSM (2013) 
Equation 3.7. Efficiency (%) 
  Efficiency = Estimated VO2 / Measured VO2 x 100 
Equation 3.8. Work rate (watts, W) 
  W = body mass (kg) x 9.8 x sin[arctan(grade)] x speed (m•sec-1)  
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Table Captions 
Table 3.1.  Characteristics of the sample 
 
Table 3.2. Cardiopulmonary outcomes across the protocol by group 
 
Table 3.3. Cardiopulmonary outcomes across the protocol by group and elevated body 
fatness 
Table 3.4. Cortisol concentration across the protocol by group and elevated body fatness 
 
Table 3.5. Group differences in cortisol area under the curve 
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Figure Captions 
Figure 3.1.  Exercise protocol 
 
Figure 3.2. Work load of exercise trial 
 
Figure 3.3. Efficiency during exercise trial 
 
Figure 3.4. Changes in relative heart rate across protocol 
 
Figure 3.5. Changes in absolute heart rate across protocol 
 
Figure 3.6. Changes in absolute oxygen consumption across protocol 
 
Figure 3.7. Changes in relative oxygen consumption across protocol 
 
Figure 3.8. Changes in ventilatory exchange across protocol 
 
Figure 3.9. Change in cortisol across protocol 
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Table 3.1.  Characteristics of the sample 
Demographic characteristic Typically developing (n=14) Down syndrome (n=12) p 
Female, n(%) 7 (50.0%) 6 (50.0%) 1.00 a 
Age (years) 15.47 (1.78) 15.24 (2.01) .764 b 
Tanner (III-V) 3.96 (0.82) 3.92 (0.79) .882 b 
Caucasian, n(%) 14 (100%) 11 (91.7%) .271 a 
Height  167.01 (9.68) 147.86 (8.43) <.001 b* 
Weight 60.27 (15.27) 58.15 (9.61) .682 b 
BMI 21.39 (3.88) 26.55 (3.50)   .002 b* 
CDC-BMI %ile 55.90 (26.18) 88.50 (12.73)   .001 b* 
DS-BMI %ile  68.12 (18.94) -- -- 
Percent Body Fat 25.81% (7.57%) 32.62% (2.61%)   .047 b* 
Elevated Body Fat, n(%) 3 (21.43%) 8 (66.67%)   .020 a* 
 
Note: Values are Mean (Standard Deviation) unless otherwise noted; Abbreviations: n = frequency, % = proportion of sample, BMI = 
body mass index (kg/m2), CDC-BMI = Centers for Disease Control and Prevention growth chart (Kuczmarski et al., 2000), DS-BMI = 
Down syndrome specific growth chart (Zemel et al., 2015); %ile = BMI percentile. 
a Pearson’s chi-square test (X2) 
b Independent samples t-test (t) 
* p < .05, bolded 
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Table 3.2. Cardiopulmonary outcomes across the protocol by group 
 
Variables T1 Baseline 
T2 
Exercise 
T3 
Recovery A 
T4 
Recovery B 
  TD DS TD DS TD DS TD DS 
Relative Heart Rate 
(%HRmax) 
34.50  
(1.46) 
43.10 *  
(1.58) 
73.90 †‡  
(0.68) 
76.30 *†‡  
(0.74) 
39.80 †‡  
(1.38) 
47.30 *†‡  
(1.49) 
38.30 †  
(1.53) 
46.60 *†  
(1.65) 
Absolute Heart Rate 
(bpm) 
70.62  
(2.85) 
73.42  
(3.07) 
151.16 †‡  
(1.30) 
129.96 *†‡  
(1.41) 
81.36 †‡  
(2.61) 
80.54 †‡  
(2.82) 
78.44 †‡  
(2.86) 
79.39 †  
(3.09) 
Absolute VO2 
(mL•min-1) 
253.37  
(20.65) 
245.20  
(22.31) 
1653.82 †‡  
(73.60) 
1111.36 *†‡  
(79.51) 
270.50 ‡  
(14.16) 
268.92 ‡ 
(15.29) 
271.60  
(14.54) 
270.49  
(16.71) 
Relative VO2 
(mL•kg-1•min-1) 
4.36 
(0.24) 
4.20  
(0.29) 
28.16 †‡ 
(1.34) 
18.65 *†‡ 
(1.60) 
4.65 ‡ 
(0.22) 
4.63 ‡ 
(0.26) 
4.66  
(0.25) 
4.62  
(0.29) 
Ventilatory Exchange 
(L•min-1) 
8.26  
(0.63) 
7.64  
(0.68) 
42.96 †‡  
(2.25) 
29.73 *†‡  
(2.43) 
8.83 ‡  
(0.46) 
8.14 ‡ 
(0.50) 
8.58  
(0.49) 
7.93  
(0.53) 
 
Estimated Marginal Means (Standard Error) controlling for sex, age, and Tanner stage. 
Abbreviations: TD = typically developing, DS = Down syndrome; %HRmax = percent of predicted maximal heart rate; VO2 = oxygen 
consumption. 
Pairwise comparisons with Bonferroni adjustments examined group differences. 
* Differences between TD and DS, p < .05 
† Differences between Time 1 (baseline) and each time point, p < .05 
‡ Differences between each time point and the preceding time point (ti – 1), p < .05 
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Table 3.3. Cardiopulmonary outcomes across the protocol by group and elevated body fatness 
Variables T1 Baseline 
T2 
Exercise 
T3 
Recovery A 
T4 
Recovery B 
Typically Developing Normal BF Elevated BF Normal BF Elevated BF Normal BF Elevated BF Normal BF Elevated BF 
Relative Heart Rate 
(%HRmax) 
32.80 
(1.50) 
41.00 * 
(2.90) 
73.50 †‡ 
(0.80) 
75.30 †‡ 
(1.50) 
39.00 †‡ 
(1.60) 
42.00 ‡ 
(3.10) 
37.30 †‡ 
(1.70) 
42.00 
(3.40) 
Absolute Heart Rate 
(bpm) 
67.04 
(2.88) 
83.75 * 
(5.56) 
150.41 †‡ 
(1.50) 
153.91 †‡ 
(2.90) 
79.91 †‡ 
(3.01) 
86.69 ‡ 
(5.82) 
76.43 †‡ 
(3.25) 
85.82 
(6.29) 
Absolute VO2 
(mL•min-1) 
231.03 
(21.96) 
335.49 * 
(42.42) 
1680.35 †‡ 
(86.27) 
1555.49 †‡ 
(166.59) 
260.83 ‡ 
(16.15) 
306.03 ‡ 
(31.18) 
261.15 
(16.23) 
310.38 
(31.34) 
Relative VO2 
(mL•kg-1•min-1) 
4.37 
(0.27) 
4.30 
(0.59) 
30.05 †‡ 
(1.25) 
19.73 *†‡ 
(2.71) 
4.80 ‡ 
(0.24) 
4.03 ‡ 
(0.52) 
4.80 
(0.26) 
4.03  
(0.56) 
Ventilatory 
Exchange (L•min-1) 
7.96 
(0.74) 
9.38 
(01.42) 
45.51 †‡ 
(2.36) 
33.60 *†‡ 
(4.55) 
8.74 ‡ 
(0.55) 
9.15 ‡ 
(1.06) 
8.52 
(0.56) 
8.84 
(1.08) 
         
Down syndrome         
Relative Heart Rate 
(%HRmax) 
42.00 # 
(2.50) 
43.50 
(1.80) 
76.3 †‡ 
(1.30) 
76.30 †‡ 
(0.90) 
46.40 #‡ 
(2.70) 
47.70 †‡ 
(1.90) 
46.20 # 
(2.90) 
46.80 
(2.10) 
Absolute Heart Rate 
(bpm) 
71.86 
(4.52) 
74.20 
(3.40) 
130.22 #†‡ 
(2.51) 
129.82 #†‡ 
(1.78) 
79.32 ‡ 
(5.05) 
81.16 †‡ 
(3.57) 
78.91 
(5.45) 
79.63 
(3.85) 
Absolute VO2 
(mL•min-1) 
247.43 
(36.76) 
244.00 
(25.98) 
1070.26 †‡ 
(144.40) 
1132.31 #†‡ 
(102.05) 
268.20 ‡ 
(27.03) 
269.25 ‡ 
(19.10) 
288.78 
(27.16) 
261.17 
(19.20) 
Relative VO2 
(mL•kg-1•min-1) 
4.67 
(0.51) 
3.97 
(0.36) 
19.79 #†‡ 
(2.34) 
17.93 †‡ 
(1.64) 
5.02 ‡ 
(0.44) 
4.42 ‡ 
(0.31) 
5.37 
(0.48) 
4.24 
(0.34) 
Ventilatory 
Exchange (L•min-1) 
7.98 
(1.23) 
7.47 
(0.87) 
29.00 #†‡ 
(3.95) 
30.11 †‡ 
(2.79) 
8.52 ‡ 
(0.92) 
7.95 ‡ 
(0.65) 
8.89 
(0.94) 
7.45 
(0.66) 
 
Estimated Marginal Means (Standard Error) controlling for sex, age, and Tanner stage. Pairwise comparisons with Bonferroni adjustments 
examined group differences. 
Abbreviations:%HRmax = percent of predicted maximal heart rate; VO2 = oxygen consumption. 
* Within disability grouping, differences between normal and elevated fatness, p < .05 
# Within body fatness grouping, differences between TD and DS, p < .05 
† Differences between Time 1 (baseline) and each time point, p < .05 
‡ Differences between each time point and the preceding time point (ti – 1), p < .05 
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Table 3.4. Cortisol concentration across the protocol by group and elevated body fatness 
 
Cortisol (μg/dL) T1 Baseline 
T2 
Exercise 
T3 
Recovery A 
T4 
Recovery B 
Typically Developing 0.22 (0.03) 0.21 (0.03) 0.20 (0.03) 0.20 (0.03) 
Typically Developing – Normal BF 0.19 (0.03) 0.18 (0.04) 0.19 (0.03) 0.19 (0.04) 
Typically Developing – Elevated BF 0.32 (0.06) 0.30 (0.07) 0.22 (0.06) 0.23 (0.07) 
Down syndrome 0.18 (0.03) 0.20 (0.04) 0.20 (0.03) 0.18 (0.04) 
Down syndrome – Normal BF 0.13 (0.05) 0.14 (0.06) 0.14 (0.05) 0.14 (0.06) 
Down syndrome – Elevated BF 0.21 (0.04) 0.23 (0.04) 0.23 (0.04) 0.20 (0.04) 
     
Effect size (Cohen’s d)     
Between disability groups .351 .077 .057 .176 
Within TD, difference by BF 1.03 .875 .385 .370 
Within DS, difference by BF 1.09 1.01 .824 .536 
Within NBF, difference by DS .651 .461 .391 .352 
Within EBF, difference by DS .882 .435 .035 .314 
 
Estimated Marginal Means (Standard Error) controlling for sex, age, and Tanner stage. 
Abbreviations: BF = body fatness, TD = typically developing, DS = Down syndrome, NBF = normal body fatness, EBF = elevated 
body fatness 
Pairwise comparisons with Bonferroni adjustments and Cohen’s d effect size examined group differences. 
* p < .05 (no observations) 
d > .80, bolded 
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Table 3.5. Group differences in cortisol area under the curve 
 
  
AUCg 
T1:T4   
Full 
AUCg 
T1:T2   
Exercise 
AUCg 
T2:T4  
Recover 
AUC∆ 
T1:T4   
Full 
AUC∆ 
T1:T2   
Exercise 
AUC∆ 
T2:T4  
Recover 
Group Differences       
Typically     
Developing 
15.16 
(2.21) 
6.64 
(0.88) 
8.52 
(1.41) 
-1.84 
(1.23) 
-0.21 
(0.29) 
0.47 
(0.23) 
Down             
syndrome 
12.08 
(2.07) 
4.76 
(0.82) 
7.31 
(1.32) 
0.71 
(1.16) 
0.18 
(0.28) 
-0.19 
(0.21) 
Typically Developing – 
Normal BF 
12.47 
(2.04) 
5.04 
(0.81) 
7.43 
(1.30) 
-0.27 
(1.40) 
-0.15 
(0.27) 
-0.01 
(0.21) 
Typically Developing – 
Elevated BF 
17.86 
(3.94) 
8.25 
(1.56) 
9.61 
(2.51) 
-3.40 
(2.20) 
-0.26 
(0.53) 
0.95 
(0.40) 
Down syndrome – 
Normal BF 
9.31 
(3.41) 
3.75 
(1.36) 
5.56 
(2.18) 
0.31 
(1.91) 
0.04 
(0.46) 
-0.11 
(0.35) 
Down syndrome – 
Elevated BF 
14.85 
(2.41) 
5.78 
(0.96) 
9.06 
(1.54) 
1.10 
(1.35) 
0.32 
(0.32) 
-0.26  
(0.25) 
        
Effect Size (Cohen’s d)       
Between          
disability groups .112 .246 .015 .476 .457 .511 
Within TD,     
difference by BF .778 .994 .587 .706 .021 1.338 * 
Within DS,     
difference by BF 1.011 1.068 .867 .042 .255 .069 
Within NBF,  
difference by DS .468 .544 .388 .533 .567 .355 
Within EBF,  
difference by DS .432 .728 .228 .800 .339 1.044 † 
 
Estimated Marginal Means (Standard Error) controlling for sex, age, and Tanner stage. 
Abbreviations: BF = body fatness, TD = typically developing, DS = Down syndrome, NBF = 
normal body fatness, EBF = elevated body fatness 
Pairwise comparisons with Bonferroni adjustments and Cohen’s d effect size examined group 
differences. 
* p < .05 
† p < .10 (trending toward significance) 
d > .80, bolded 
 
 
 
 
134 
Figure 3.1.  Exercise protocol 
 
 
 
Protocol for laboratory visit to measure respiratory exchange and cortisol before, during 
and after submaximal graded exercise. Black dots indicate time points with salivary 
cortisol samples. Red boxes indicate periods for respiratory exchange analysis. 
 
 
135 
Figure 3.2.  Work load of exercise trial 
 
 
 
Means ± SE 
Typical development (□); Down syndrome (■); Down syndrome (with 0 watts data removed, ) 
* p < .05  
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Figure 3.3.  Efficiency during exercise trial 
 
 
 
Means ± SE 
Typical development (□); Down syndrome (■) 
* p < .05  
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Figure 3.4.  Changes in relative heart rate across protocol 
 
 
 
Relative heart rate (% of predicted HRmax). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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Figure 3.5.  Changes in absolute heart rate across protocol 
 
 
 
Absolute heart rate (beats per minute). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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Figure 3.6.  Changes in absolute oxygen consumption across protocol 
 
 
 
Absolute oxygen consumption (VO2; mL•min-1). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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Figure 3.7.  Changes in relative oxygen consumption across protocol 
 
 
 
Relative oxygen consumption (VO2; mL•kg-1•min-1). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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Figure 3.8.  Changes in ventilatory exchange across protocol 
 
 
 
Ventilatory Exchange (VE, L•min-1). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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Figure 3.9.   Change in cortisol across protocol 
 
 
 
 
Cortisol concentration (μg/dL). Values are means ± SE. 
* Significant difference between typically developing (TD) and Down syndrome (DS), p < .05 
† Significant difference between normal and elevated body fatness in DS, p < .05 
‡ Significant difference between normal and elevated body fatness in TD, p < .05 
# Significant difference between TD and DS in adolescents with elevated body fatness, p < .05 
• Significant difference between TD and DS in adolescents with normal body fatness, p < .05 
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CHAPTER 4 
Conclusions 
High rates of obesity represent a source of health disparity for individuals with Down 
syndrome.  Prior to the current obesity epidemic (Eaton et al., 2008; Ogden, Carroll, Kit & 
Flegal, 2012; Ogden, Carroll, Kit & Flegal, 2014), researchers were already documenting a 
greater overweight prevalence among youth with Down syndrome (Chumlea & Cronk, 1981; 
Cronk, 1978; Cronk, Chumlea & Roche, 1985; Cronk et al., 1988).  Recent literature reflects a 
growing problem of excess weight for height for many youth with Down syndrome.  Prevalence 
estimates have been reported high as 60.9% for overweight status and 31.2% for obesity in youth 
with Down syndrome (Bandini, Fleming, Scampini, Gleason & Must, 2012; Gonzalez-Aguero, 
Ara, Moreno, Vicente-Rodriguez & Casajus, 2011; Grammatikopoulou et al., 2008; Krause, 
Ware, McPherson, Lennox & O’Callaghan, 2015; Myrelid, Gustafsson, Ollars & Anneren, 2002; 
Rimmer, Yamaki, Lowry, Wang & Vogel, 2010; Styles, Cole, Dennis & Preece, 2002; van 
Gameren-Oosterom et al., 2012).  High rates of overweight and obesity persist and expand 
throughout adulthood (Bhaumik, Watson, Thorp, Tyrer & McGrother, 2008; Melville, Cooper, 
McGrother, Thorp & Collacott, 2005; Melville, Hamilton, Hankey, Miller & Boyle, 2008; 
Rubin, Rimmer, Chicoine, Braddock & McGuire, 1998; Stancliffe et al., 2011).  These data 
suggest the odds of being overweight or obese are over 3 times greater than the general 
population (Rimmer, Yamaki, et al., 2010) and between 2 and 3 times greater than youth with a 
non-genetic form of intellectual disability (Bégarie, Maïano, Leconte & Ninot, 2013; Krause et 
al., 2015; Pan, Davis, Nichols, Hwang & Hsieh, 2016).  Thus, the prevention and treatment of 
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obesity for children with Down syndrome is considered a priority in both public health and 
medicine (Murray & Ryan-Krause, 2010). 
The overall focus of the dissertation was to better understand obesity in adolescents with 
Down syndrome.  This included determining how to properly measure adiposity and examining 
associations between adiposity, health behaviors, and the adrenal hormone cortisol.  There were 
four specific aims that were addressed through the three dissertations studies.  First, I examined 
differences in body composition between adolescents with and without Down syndrome using 
metrics of BMI and DXA.  The purpose was to examine adiposity between groups and infer on 
how measurement choices can impact the interpretations of obesity in this population.  Second, I 
described two primary health behaviors, physical activity and diet, and examined the associations 
of each health behavior with adiposity.  Third, I examined cortisol levels during daily life to 
establish diurnal patterns as well as during exercise to quantify cortisol response.  To my 
knowledge, this research is the first study to examine diurnal cortisol patterns, and only the 
second study to examine exercise cortisol responses in individuals with Down syndrome.  
Fourth, I examined group differences in cortisol activity between various sub-groups including 
adolescents with and without Down syndrome, with and without elevated body fatness, and with 
and without moderate levels of physical activity.  The key findings and implications from these 
specific aims are discussed here.  
Measuring body composition 
This study was one of the few to use DXA measurement in persons with Down syndrome 
(Bandini et al., 2012; Baptista, Varela & Sardinha, 2005; Esco, Nickerson, Bicard, Russell & 
Bishop, 2016; Gonzalez-Aguero et al., 2011; Guijarro, Valero, Paule, Gonzalez-Macias & 
Riancho, 2008; Loveday, Thompson & Mitchell, 2012; Nickerson et al., 2015; Wendel et al., 
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2016). Body fat percentages as measured by DXA were significantly higher in adolescents with 
Down syndrome compared to controls, yet the magnitude of the effect sizes were considerably 
smaller than when differences were examined with BMI.  Large differences were also observed 
in body fat distributions, with greater proportions of fat mass localized to the abdomen among 
adolescents with Down syndrome.  Furthermore, the 2x2 analysis identified substantial 
misclassification of BMI categories compared to elevated levels of body fat.  All of these 
findings point toward the potential for overestimation of obesity using BMI and reinforce the 
need for more advanced body composition measurement in Down syndrome.  Based on the 
results of study 1, only DXA-derived adiposity was used in subsequent studies. 
All of my results regarding body composition are consistent with literature on adolescents 
with Down syndrome include reports of high body fat percentage (Bandini et al., 2012; Baptista 
et al., 2005; Esco et al., 2016; Guijarro et al., 2008; Loveday et al., 2012; Nickerson et al., 2015; 
Wendel et al., 2016), low efficiency in categorization based on BMI (Bandini et al., 2012), and 
greater distribution of fat in the abdominal region (Gonzalez-Aguero et al., 2011).  However, the 
body of literature from which these comparisons are drawn remains small.  
The strength of this body composition measurement must also be weighed against the 
considerable cost and effort needed to use DXA.  Sample size is a limitation in all three studies 
of the dissertation.  The small sample size is due, at least in part, to difficulties with recruiting 
participants capable of coming to campus to complete the DXA scan within business hours.  
While cost was not a restricting factor within this set of studies, at a rate of $103 to $140 per 
DXA scan, there is considerably more cost to conducting this type of body composition 
measurement compared to field measures.  However, compared to the best available imaging 
techniques (e.g. computed tomography and magnetic resonance imaging), DXA is more cost-
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effective, time-efficient, and less invasive (Kendler et al., 2013).  An area for future research 
should be to use DXA to validate field-based measures of body composition for persons with 
Down syndrome (Esco et al., 2016; Nickerson et al., 2015). 
Associations between adiposity and health behaviors 
 Weight gain, by definition, is caused by a positive ratio between calories in and calories 
out.  Thus, dietary intake and physical activity are highly relevant health behaviors to consider 
within the scope of addressing health disparities in obesity. While the amount of research 
conducted in these health behaviors for persons with Down syndrome continues to expand, in 
particular physical activity, we still have insufficient literature to make definitive conclusions.   
 First, I found that physical activity levels were very low among the sample. This was 
particularly evident among the adolescents with Down syndrome.  Significant differences were 
observed between groups in light, vigorous, and moderate-to-vigorous physical activity 
categories.  Furthermore, very few participants with or without Down syndrome met 
recommended physical activity guidelines (U.S. Department of Health and Human Services, 
2008; World Health Organization, 2010).  Previous studies have also found low levels of 
physical activity in youth with Down syndrome (Esposito, MacDonald, Hornyak & Ulrich, 2012; 
Izquierdo-Gomez et al., 2014; Matute-Llorente, González-Agüero, Gómez-Cabello, Vicente-
Rodríguez & Casajús, 2013a; Matute-Llorente, González-Agüero, Gómez-Cabello, Vicente-
Rodríguez & Casajús, 2013b; Phillips & Holland, 2011; Pitetti, Baynard & Agiovlasitis, 2013; 
Shields, Dodd & Abblitt, 2009).  However, physical activity levels observed in the current 
studies were even lower than previous reports.  What is potentially concerning about this finding 
is that in our convenience sample, many of the families have participated in previous studies 
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including motor skill and physical activity interventions.  Thus, a broader sample with parents 
that are less engaged in promoting physical activity may result in even lower levels. 
 The potentially novel finding of this study was that when using percent body fat from 
DXA instead of BMI to represent obesity, the association with physical activity was stronger.  
Furthermore, in the linear regression analysis, the effect of physical activity on percent body fat 
was trending toward significance.  This findings represents the largest reported association 
between these variables within persons with Down syndrome.  Previously reported associations 
have been consistently small and non-significant (Esposito et al., 2012; Izquierdo-Gomez et al., 
2015; Nordstrom, Hansen, Paus & Kolset, 2013; Shields et al., 2009; Shields, Hussey, Murphy, 
Gormley & Hoey, 2015).  While the current findings do not reach statistical significance, the 
larger magnitude of association is promising and suggests statistical significance could be 
possible with a larger sample. 
 Second, we found significant differences in the unadjusted caloric and macronutrient 
intake between adolescents with and without Down syndrome.  However, when caloric intake 
was normalized to lean body mass and macronutrient levels were normalized to total caloric 
intake, these differences were no longer significant nor meaningful.  All of the reported dietary 
variables also appear to be consistent with recommended daily allowances (U.S. Department of 
Health and Human Services and U.S. Department of Agriculture, 2015).  There is a very limited 
body of literature on diet in youth with Down syndrome, but the current findings appear to be 
consistent with the caloric and macronutrient intake reported in previous studies (Braunschweig 
et al., 2004; Grammatikopoulou et al., 2008; Hopman et al., 1998; Luke, Sutton, Schoeller & 
Roizen, 1996; Samarkandy, Mohamed & Al-Hamdan, 2012; Soler Marin & Xandri Graupera, 
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2011).  It remains unclear if the dietary intake patterns reported are consistent with excess 
calories relative to energy expenditure, as resting metabolic rate was not measured.  
Cortisol function 
Cortisol was selected as a hormone of interest due to the potential to promote metabolic 
dysregulation and contribute to excess body fat, particularly in the abdomen (Adam & Epel, 
2007; Bjorntorp, 1996, 2001; De Vriendt, Moreno & De Henauw, 2009; Rodriguez et al., 2015). 
In typically developing children and adolescents, associations suggesting that cortisol levels are 
higher in individuals with greater adiposity have been reported (Barat et al., 2007; Guzzetti, 
Pilia, Ibba & Loche, 2014; Hill, Eisenmann, Gentile, Holmes & Walsh, 2011; Misra et al., 2008; 
Reinehr et al., 2014; Rosmalen et al., 2005; Weigensberg, Toledo-Corral & Goran, 2008). 
Evidence of cortisol function in Down syndrome is very limited, but recent data suggest that 
there may be differences in cortisol levels between persons with and without Down syndrome 
(Bricout et al., 2008).  To better understand how cortisol operates in adolescents with Down 
syndrome, I studied the hormone activity with regards to diurnal patterns across the day as well 
as the exercise response within a controlled protocol. 
First, I found that cortisol followed the expected diurnal pattern for both adolescents with 
and without Down syndrome.  Although there were no significant differences, cortisol levels 
were higher when directly comparing adolescents with and without Down syndrome.  Significant 
differences began to appear in the diurnal cortisol patterns when participations were further 
divided by elevated body fatness and by meeting physical activity thresholds. Multiple 
comparisons within adolescents with Down syndrome were statistically significant.  Differences 
did not reach significance among adolescents with typical development, but followed a similar 
pattern.  Although there are issues with group composition, the findings in study 2 are consistent 
157 
 
with a positive association between cortisol and adiposity (Barat et al., 2007; Guzzetti et al., 
2014; Hill et al., 2011; Misra et al., 2008; Reinehr et al., 2014; Rosmalen et al., 2005; 
Weigensberg et al., 2008) and negative association between cortisol and physical activity 
(Martikainen et al., 2014). 
Second, I found that cortisol did not significantly (or meaningfully) respond to the 
exercise bout prescribed for either adolescents with Down syndrome or with typical 
development.  An exercise response was expected, especially for typically developing 
adolescents. However, other studies in adolescents have not observed a cortisol response to 
exercise either (Eliakim et al., 2006; Galassetti et al., 2006).  Similar to study 2, direct 
differences between groups with and without Down syndrome were not significant.  However, 
average cortisol levels were lower among adolescents with Down syndrome.  This is the opposite 
direction as study 2, but similar to the pattern observed previously in young adults males with 
Down syndrome (Bricout et al., 2008).  When stratified by body fatness, cortisol levels were 
moderately higher in adolescents with greater adiposity. This was observed in both adolescents 
with and without Down syndrome.  While no significant differences were observed, large effect 
sizes were observed in multiple comparisons.  In general, the pattern of difference showed 
associations of higher cortisol in adolescents with greater body fatness, consistent with many 
previous studies (Barat et al., 2007; Guzzetti et al., 2014; Hill et al., 2011; Misra et al., 2008; 
Ondrak, McMurray, Hackney & Harrell, 2011; Reinehr et al., 2014; Rosmalen et al., 2005; 
Ruttle et al., 2013; Weigensberg et al., 2008). 
The question remains, what do these two studies tell us about cortisol differences 
between adolescents with and without Down syndrome?  During the exercise trial (study 3), 
cortisol levels were slightly lower in adolescents with Down syndrome compared to adolescents 
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with typical development.  These differences became wider and exhibited large effect sizes when 
stratified by body fatness.  For example, adolescents with Down syndrome who had elevated 
body fatness exhibited lower cortisol levels at baseline compared to adolescents with typical 
development who also had elevated body fatness (d = .88, Figure 3.9).  In the daily diurnal 
patterns (study 2), adolescents with Down syndrome had slightly higher cortisol levels across the 
day.  However, if the patterns are compared between disability groups within body fatness and 
physical activity interactions, the cortisol levels appear to be lower.  For example, adolescents 
with Down syndrome who had normal body fatness and engaged in less than 30 minutes of 
physical activity per day exhibited lower levels of cortisol across the day compared to typically 
developing adolescents who also had normal body fatness and engaged in less than 30 minutes of 
physical activity (p = .05; Figures 2.2 and 2.3). This relationship is difficult to interpret, 
particularly given the sub-group with Down syndrome (with normal body fatness and met the 
threshold of 30 minutes of physical activity) had oddly high diurnal cortisol.  Lower levels of 
cortisol would be consistent with the resting and exercise levels observed by (Bricout et al., 
2008).  
Moving forward 
Due to the high levels of obesity and low levels of physical activity observed in 
adolescents with Down syndrome, directed health promotion interventions are of great need in 
this population. The number of physical activity interventions targeting populations with 
intellectual disabilities, including Down syndrome, remain limited compared to the general 
population (Rimmer, Chen, McCubbin, Drum & Peterson, 2010). It is suggested that future 
research address this paucity through rigorous randomized-control designs when feasible, with 
tight sample composition to limit potential confounders, and through demonstrating replicability 
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of positive interventions (Rimmer et al., 2010).  Furthermore, I am in favor of intervention 
approaches following guidelines proposed by Drum and colleagues (2009) for translational 
research.  These guideline encourage 1) a focus on community-based programing, 2) using 
theoretical frameworks, process evaluations, and appropriate measures to evaluate outcomes; 3) 
involve individuals and families, while considering the  unique beliefs, practices, and values of 
participants; and 4) being socially, programmatically, and environmentally accessible.  This 
dissertation reinforces the need to increase physical activity in adolescents with Down syndrome 
and presents a potential covariate (cortisol) that may assist with understanding within-group 
differences in obesity.  It is critical, however, to focus attention on creating these interventions 
and translational programs that can provide direct benefits to participants with Down syndrome. 
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